284 results found.

Pneumonia, or Blood Stream Infection Clinical Trial using colistin and meropenem; colistin and placebo

Kaye, Keith, M.D., M.P.H. - Recruiting 18 years to 95 years.
- Randomized Controlled Trial for the Treatment of Extensively Drug-Resistant Gram-negative Bacilli.
colistin and meropenem; colistin and placebo

Staphylococcal Infection Clinical Trial using XF-73 in 4% Klucelr gel; XF-73 in 2% Klucelr gel; Placebo in 4% Klucelr gel

National Institute of Allergy and Infectious Diseases (NIAID) - Recruiting 18 years to 45 years.
- A Two-Part Phase I Study to Establish and Compare the Safety and Local Tolerability of Two Nasal Formulations of XF-73 for Decolonization of Staphylococcus Aureus: A Previously Investigated 0.5 mg/g Viscosified Gel Formulation Versus a Modified Formulation.
XF-73 in 4% Klucelr gel; XF-73 in 2% Klucelr gel; Placebo in 4% Klucelr gel

Intra-abdominal Infection Clinical Trial using Tigecycline; Imipenem/cilastatin

Pfizer - Recruiting 18 years or older.
- A Multicenter, Double-Blind, Randomized, Comparison Study Of The Efficacy And Safety Of Tigecycline To Imipenem/Cilastatin To Treat Complicated Intra-Abdominal Infections In Hospitalized Subjects.
Tigecycline; Imipenem/cilastatin

Chronic Hepatitis C, Hepatitis C Virus, or Compensated Cirrhosis Clinical Trial using ABT-493; ABT-530; ABT-450/r/ABT-267; ABT-333; Ribavirin (RBV)

AbbVie - Recruiting 18 years to 70 years.
- A Randomized, Open-Label, Dose Ranging Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Multiple Doses of ABT-493 and ABT-530 in Adult Subjects With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection.
ABT-493; ABT-530; ABT-450/r/ABT-267; ABT-333; Ribavirin (RBV)

HIV-1 Infection Clinical Trial using Raltegravir

Merck Sharp & Dohme Corp. - Recruiting 18 years or older.
- A Non-interventional Cohort Study for the Assessment of the Efficacy of RALTEGRAVIR 400 mg Administered Twice Daily in Combination With Other Antiretroviral Drugs to Treat Infection With the Human Immunodeficiency Virus 1 (HIV-1) in Adults and Aging Patients (ò 50 Years) Under Conditions That Are Representative of the Nationwide Treatment of HIV-positive Patients in Germany.
Raltegravir

Human Papillomavirus (HPV) Infection Clinical Trial using GSK Biologicals' HPV Vaccine GSK580299; Engerix-BT

GlaxoSmithKline - Recruiting 12 years to 15 years.
- Evaluation of the Effectiveness of Two Vaccination Strategies Using GlaxoSmithKline Biologicals' HPV Vaccine GSK580299 (Cervarix TM) Administered in Healthy Adolescents.
GSK Biologicals' HPV Vaccine GSK580299; Engerix-BT

Plasmodium Vivax Infection Clinical Trial using Artemether-lumefantrine combination; Primaquine; Chloroquine

Centers for Disease Control and Prevention - Recruiting 1 year or older.
- Ethiopia Antimalarial in Vivo Efficacy Study 2012: Evaluating the Efficacy of Artemether-lumefantrine Alone Compared to Artemether-lumefantrine Plus Primaquine and Chloroquine Alone Compared to Chloroquine Plus Primaquine for Plasmodium Vivax Infection.
Artemether-lumefantrine combination; Primaquine; Chloroquine

Infection Clinical Trial using Colistin

University of Zurich - Recruiting 18 years or older.
- Colistimethate and Colistin Pharmacokinetics in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy (CRRT).
Colistin

Clostridium Difficile Colitis Clinical Trial using FMT; placebo

MemorialCare Health System - Recruiting 1 year to 21 years.
- A Randomized, Placebo-controlled Pilot Trial to Administer Fecal Microbial Therapy (Stool Transplant) or Placebo in Children Ages 8 to 18 With Recurrent C. Difficile Infection.
FMT; placebo

HIV Infections Clinical Trial using Methotrexate (MTX); Placebo; Folic acid

National Institute of Allergy and Infectious Diseases (NIAID) - Recruiting 40 years or older.
- Effect of Reducing Inflammation With Low Dose Methotrexate on Inflammatory Markers and Endothelial Function in Treated and Suppressed HIV Infection.
Methotrexate (MTX); Placebo; Folic acid

Hepatitis C Clinical Trial

Hologic, Inc. - Recruiting 18 years or older.
- Collection of Plasma and Serum Samples From Individuals Initiating Therapy With Sofosbuvir for Chronic Hepatitis C Virus Infection for the Clinical Evaluation of the Aptima HCV Quant Dx Assay.

Hepatitis C, Chronic, or Infection Clinical Trial using TMC435; Pegylated interferon alfa-2a (PegIFNà-2a); Ribavirin (RBV)

Janssen-Cilag International NV - Recruiting 18 years to 70 years.
- A Phase 3, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of TMC435 Plus Pegylated Interferon Alfa-2a and Ribavirin Administered for 12 Weeks in Treatment-Na‹ve Subjects With Chronic Genotype 1 or Genotype 4 HCV Infection.
TMC435; Pegylated interferon alfa-2a (PegIFNà-2a); Ribavirin (RBV)

Helicobacter Pylori Infection Clinical Trial using Breath Test Collection bags

Exalenz Bioscience LTD. - Recruiting 18 years or older.
- Clinical Validation Study to Evaluate Presence of H. Pylori With 13C-Urea Breath Test Using the Dual Mode BreathIDr Hp System Compared to Congruent Biopsy Results.
Breath Test Collection bags

Tuberculosis, or HIV Infections Clinical Trial using Rifapentine (RPT); Isoniazid (INH); Pyridoxine (Vitamin B6)

National Institute of Allergy and Infectious Diseases (NIAID) - Recruiting 13 years or older.
- Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection.
Rifapentine (RPT); Isoniazid (INH); Pyridoxine (Vitamin B6)

Human Immunodeficiency Virus-type 1 Infection Clinical Trial using Rilpivirine; Efavirenz; Tenofovir disoproxil fumarate; Emtricitabine

Janssen-Cilag International NV - Recruiting 18 years or older.
- A Phase 3b, Randomized, Open-label Clinical Study to Demonstrate Non-inferiority in Virologic Response Rates of HIV-1 RNA Suppression <400 Copies/mL of TDF/FTC/RPV Versus TDF/FTC/EFV in First-line Antiretroviral NNRTI-based Suppressed Patients. Switching At Low HIV-1 RNA Into Fixed Dose Combinations (SALIF).
Rilpivirine; Efavirenz; Tenofovir disoproxil fumarate; Emtricitabine

Transplantation Infection Clinical Trial using Cidofovir; No Cidofovir

M.D. Anderson Cancer Center - Recruiting 6 years or older.
- A Phase II Randomized Study of Cidofovir Versus Best Supportive Care for Polyomavirus Hominis Type I (BK) Virus Related Hemorrhagic Cystitis After Stem Cell Transplant.
Cidofovir; No Cidofovir

Disorder Related to Bone Marrow Transplantation, Leukemia, or Tra Clinical Trial using Fludarabine; Clofarabine; Busulfan; Thymoglobulin; Stem Cell Infusion; Tacrolimus; Methotrexate

M.D. Anderson Cancer Center - Recruiting 3 years to 70 years.
- A Randomized Study of Once Daily Fludarabine-Clofarabine Versus Fludarabine Alone Combined With Intervenous Busulfan Followed by Allogeneic Hemopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS).
Fludarabine; Clofarabine; Busulfan; Thymoglobulin; Stem Cell Infusion; Tacrolimus; Methotrexate

HIV Infection, or Unspecified Adult Solid Tumor, Protocol Specifi Clinical Trial using cabozantinib-s-malate; pharmacological study; laboratory biomarker analysis

National Cancer Institute (NCI) - Recruiting 18 years or older.
- Phase I Trial of Cabozantinib (XL184) for Advanced Solid Tumors in Persons With HIV Infection.
cabozantinib-s-malate; pharmacological study; laboratory biomarker analysis

Ventilator Associated Pneumonia (VAP), Infection, Antibiotic-Asso Clinical Trial using L. rhamnosus GG - Probiotic

McMaster University - Recruiting 18 years or older.
- Probiotics: Prevention of Severe Pneumonia and Endotracheal Colonization Trial (PROSPECT): A Feasibility Clinical Trial.
L. rhamnosus GG - Probiotic

Childhood Infections Clinical Trial

Helmholtz Centre for Infection Research - Recruiting 1 year to 3 years.
- The Investigation of Methods to Capture Acute Respiratory and Gastrointestinal Infections of Children Aged 1 to 3 Years. Feasibility Study for the Braunschweig Birth Cohort L”wenKIDS (Infections and the Development of the Immune System).

Kidney Transplantation Recipients Clinical Trial

Asan Medical Center - Recruiting 16 years to 90 years.
- Assessment of CMV-specific ELISPOT Assay for Predicting CMV Infection in Kidney Transplant Recipients (ACE-KT).

Kidney Transplantation Clinical Trial

Asan Medical Center - Recruiting 16 years or older.
- Assessment of VZV-specific ELISPOT Assay for Predicting VZV Infection in Kidney Transplant Recipients (AVE-KT).

Bone Marrow Transplantation Clinical Trial

Asan Medical Center - Recruiting 16 years or older.
- Assessment of CMV-specific ELISPOT Assay for Predicting CMV Infection in Bone Marrow Transplant Recipients (ACE-BMT).

Diabetic Foot, Foot Ulcer, Leg Ulcer, Bacteremia, or Infection Clinical Trial using Antibody assays for S. aureus; Basic blood work

Centre Hospitalier Universitaire de NÄ«mes - Recruiting 18 years or older.
- Observational and Comparative Study on the Immune Response of Patients With Chronic, Staphylococcus Aureus-infected Wounds (Localized Infections Versus Bacteremia).
Antibody assays for S. aureus; Basic blood work

HIV-1 Infection Clinical Trial

University of North Carolina, Chapel Hill - Recruiting 18 years or older.
- CID 1213 - Assessing Short and Long Term Compliance With Caloric Intake in HIV Positive Women After Switching to Fixed Dose Combination of Rilpivirine, Emtricitabine and Tenofovir DF.

Anxiety, Pain, or Surgical Site Infection Clinical Trial using cellular device/computers

Duke University - Recruiting 18 years or older.
- Using Mobile Phone Text Messaging and E-mailing to Decrease Anxiety, Pain, Follow-up Visits and Improve Reporting of Surgical Site Infection After Spine Surgery: A Double-Blind Randomized Trial.
cellular device/computers

Respiratory Tract Infection, Bronchitis, Bronchiolitis, or Pneumo Clinical Trial using xTAG RVP v3

Luminex Molecular Diagnostics - Recruiting N/A or older.
- A Two Arm, Multi-Centre Clinical Evaluation of the xTAG Respiratory Viral Panel v3 Test in Patients With Clinical Signs and Symptoms of Respiratory Tract Infection.
xTAG RVP v3

Infection, or Hip Replacement Arthroplasty Clinical Trial using Cementless one-stage surgical revision

University of Aarhus - Recruiting 18 years or older.
- Cementless One-stage Revision in Fast-track Setting of the Chronic Infected Hip Arthroplasty.
Cementless one-stage surgical revision

Pneumococcal Infection Clinical Trial using Prevnar 13 (PVC13)

National Institute of Allergy and Infectious Diseases (NIAID) - Recruiting 55 years to 74 years.
- A Phase IIb, Open-Label, Dose-Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine.
Prevnar 13 (PVC13)

Staphylococcal Infection Clinical Trial using Trimethoprim-sulfamethoxazole (TS); Placebo; Clindamycin

National Institute of Allergy and Infectious Diseases (NIAID) - Recruiting 6 Months to 85 years.
- Randomized, Double-Blind Trial of Clindamycin, Trimethoprim-Sulfamethoxazole, or Placebo for Uncomplicated Skin and Soft Tissue Infections Caused by Community-Associated Methicillin-Resistant Staphylococcus Aureus.
Trimethoprim-sulfamethoxazole (TS); Placebo; Clindamycin

Malaria Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting N/A to 45 years.
- Host and Parasite Factors That Influence Susceptibility to Malaria Infection and Disease During Pregnancy and Early Childhood in Ouelessebougou and Bamako, Mali.

Intra-abdominal Infections Clinical Trial using MK-7655 250 mg with imipenem/cilastatin; MK-7655 125 mg with imipenem/cilastatin; imipenem/cilastatin with placebo; Matching placebo to MK-7655

Merck Sharp & Dohme Corp. - Recruiting 18 years or older.
- A Phase II, Randomized, Active Comparator-Controlled Clinical Trial to Study the Safety, Tolerability, and Efficacy of MK-7655 + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone in Patients With Complicated Intra-Abdominal Infection [cIAI].
MK-7655 250 mg with imipenem/cilastatin; MK-7655 125 mg with imipenem/cilastatin; imipenem/cilastatin with placebo; Matching placebo to MK-7655

Clostridium Difficile Infection Clinical Trial using MK-3415; MK-6072; MK-3415A; Placebo; SOC

Merck Sharp & Dohme Corp. - Recruiting 18 years or older.
- A Phase III, Randomized, Double-Blind, Placebo-Controlled, Adaptive Design Study of the Efficacy, Safety, and Tolerability of a Single Infusion of MK-3415 (Human Monoclonal Antibody to Clostridium Difficile Toxin A), MK-6072 (Human Monoclonal Antibody to Clostridium Difficile Toxin B), and MK-3415A (Human Monoclonal Antibodies to Clostridium Difficile Toxin A and Toxin B) in Patients Receiving Antibiotic Therapy for Clostridium Difficile Infection (MODIFY I).
MK-3415; MK-6072; MK-3415A; Placebo; SOC

Urinary Tract Infections, or Pyelonephritis Clinical Trial using MK-7655 250 mg with imipenem/cilastatin; MK-7655 125 mg with imipenem/cilastatin; imipenem/cilastatin 500 mg; Placebo to MK-7655

Merck Sharp & Dohme Corp. - Recruiting 18 years or older.
- A Phase II, Randomized, Active Comparator-Controlled Clinical Trial to Study the Safety, Tolerability, and Efficacy of MK-7655 + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone in Patients With Complicated Urinary Tract Infection (cUTI).
MK-7655 250 mg with imipenem/cilastatin; MK-7655 125 mg with imipenem/cilastatin; imipenem/cilastatin 500 mg; Placebo to MK-7655

Clostridium Difficile Infection Clinical Trial using MK-6072; MK-3415A; Placebo; SOC

Merck Sharp & Dohme Corp. - Recruiting 18 years or older.
- A Phase III, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety and Tolerability of a Single Infusion of MK-6072 (Human Monoclonal Antibody to C. Difficile Toxin B), and MK-3415A (Human Monoclonal Antibodies to C. Difficile Toxin A and B) in Patients Receiving Antibiotic Therapy for C. Difficile Infection (MODIFY II).
MK-6072; MK-3415A; Placebo; SOC

Clostridium Difficile Infection Clinical Trial using Fresh Human Biotherapy; Frozen-and-Thawed Human Biotherapy

McMaster University - Recruiting 18 years or older.
- A Prospective Randomized Multi-Centre Trial of Fresh vs. Frozen-and-Thawed Human Biotherapy (Fecal Transplant) for Recurrent Clostridium Difficile Infection.
Fresh Human Biotherapy; Frozen-and-Thawed Human Biotherapy

HIV Infection Clinical Trial using Vitamin D3 (cholecalciferol); Placebo

Harvard School of Public Health - Recruiting 18 years or older.
- Trial of Vitamin D in HIV Progression.
Vitamin D3 (cholecalciferol); Placebo

Surgical Wound Infection, Infection; Cesarean Section, Cesarean S Clinical Trial using PICO from Smith&Nephew; Standard postoperative wound dressing

Odense University Hospital - Recruiting 18 years or older.
- Use of Incisional Negative Pressure Wound Therapy for Prevention of Postoperative Infections Following Caesarean Section in Women With BMI >=30.
PICO from Smith&Nephew; Standard postoperative wound dressing

HIV-1 Infection Clinical Trial using BMS-955176; Placebo matching with BMS-955176; Atazanavir; Ritonavir; Tenofovir; Emtricitabine

Bristol-Myers Squibb - Recruiting 18 years to 55 years.
- Randomized, Placebo-Controlled, Multiple-Dose Study to Evaluate the Pharmacodynamics, Safety and Pharmacokinetics of BMS-955176 (Double-Blinded) and BMS-955176 With Atazanavir +/- Ritonavir (Open-Labeled) in HIV-1 Infected Subjects.
BMS-955176; Placebo matching with BMS-955176; Atazanavir; Ritonavir; Tenofovir; Emtricitabine

HIV Infection Clinical Trial using Maraviroc; Emtricitabine; Tenofovir disoproxil fumarate; Maraviroc placebo; Emtricitabine placebo; Tenofovir disoproxil fumarate placebo

National Institute of Allergy and Infectious Diseases (NIAID) - Recruiting 18 years or older.
- A Phase II Randomized, Double-Blind, Study of the Safety and Tolerability of Maraviroc (MVC), Maraviroc + Emtricitabine (MVC+FTC), Maraviroc + Tenofovir Disoproxil Fumarate (MVC+TDF), or Tenofovir Disoproxil Fumarate + Emtricitabine (TDF+FTC) For Pre-Exposure Prophylaxis (PrEP) To Prevent HIV Transmission in At-Risk Men Who Have Sex With Men and in At-Risk Women.
Maraviroc; Emtricitabine; Tenofovir disoproxil fumarate; Maraviroc placebo; Emtricitabine placebo; Tenofovir disoproxil fumarate placebo

Inflammation, or Fungal Infection Clinical Trial

University Medical Centre Groningen - Recruiting 18 years or older.
- Managing Voriconazole Exposure During Severe Infection; Effect of Inflammation on Voriconazole Metabolic Ratio.

Hepatitis C Clinical Trial using TT-034

Tacere Therapeutics, Inc. - Recruiting 18 years to 65 years.
- A Phase I,II Open-Label Dose Escalation Study to Evaluate the Safety and Efficacy of Single Doses of TT-034 for Subjects With Chronic Hepatitis C (CHC) Infection.
TT-034

Complicated Urinary Tract Infection,, or Complicated Intra-abdomi Clinical Trial using Ceftazidime - Avibactam ( CAZ-AVI); Best Available Therapy; Metronidazole

AstraZeneca - Recruiting 18 years to 90 years.
- An Open-Label, Randomized, Multicenter, Phase III Study of Ceftazidime Avibactam (CAZ-AVI, Formerly CAZ104) and Best Available Therapy for the Treatment of Infections Due to Ceftazidime Resistant Gram Negative Pathogens.
Ceftazidime - Avibactam ( CAZ-AVI); Best Available Therapy; Metronidazole

HIV Infection Clinical Trial using Tenofovir, Emtricitabine, Lopinavir/r; Tenofovir, Emtricitabine, Raltegravir

Hospital Clinic of Barcelona - Recruiting 18 years or older.
- Open Randomized Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1: Tenofovir + Emtricitabine + Lopinavir/Ritonavir Versus Tenofovir + Emtricitabine + Raltegravir.
Tenofovir, Emtricitabine, Lopinavir/r; Tenofovir, Emtricitabine, Raltegravir

HIV Infection Clinical Trial using Tenofovir, emtricitabine, maraviroc; Tenofovir, emtricitabine, lopinavir/r

Hospital Clinic of Barcelona - Recruiting 18 years or older.
- Open Randomized Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1: TENOFOVIR+EMTRICITABINA + LOPINAVIR/RITONAVIR VS TENOFOVIR+EMTRICITABINA + MARAVIROC.
Tenofovir, emtricitabine, maraviroc; Tenofovir, emtricitabine, lopinavir/r

Hepatitis B Chronic Infection, or Pregnancy Clinical Trial using tenofovir disoproxil fumarate; placebo

Institut de Recherche pour le Developpement - Recruiting 18 years or older.
- Phase 3, Randomized Clinical Trial to Assess the Efficacy and Safety of Tenofovir in Hepatitis B Virus Infected, s and e Antigen Positive, Pregnant Women to Prevent Perinatal Transmission Despite Infant Passive-active HBV Immunization..
tenofovir disoproxil fumarate; placebo

Systemic Infections Clinical Trial using CAZ-AVI

AstraZeneca - Recruiting 3 Months to 17 years.
- A Phase I Study to Assess the Pharmacokinetics, Safety and Tolerability of a Single Dose of Ceftazidime-Avibactam (CAZ-AVI) in Children From 3 Months of Age to <18 Years Who Are Receiving Systemic Antibiotic Therapy for Suspected or Confirmed Infection.
CAZ-AVI

Tuberculosis Clinical Trial using Enhanced TB IC Package

Centers for Disease Control and Prevention - Recruiting 18 years to 45 years.
- Evaluation of an Enhanced Tuberculosis Infection Control Intervention in Healthcare Facilities in Vietnam and Thailand.
Enhanced TB IC Package

Hepatitis C, Chronic Clinical Trial

Hoffmann-La Roche - Recruiting 18 years or older.
- Prospective Multicenter Observational Trial to Evaluate Correlation Between Liver Biopsy and Transient Elastography in Liver Fibrosis Assessment and Correlation Between Viral Kinetics and Transient Elastography Evolution During Hepatitis C Treatment in a Population of Chronic HCV Infected Patients.

Chronic Hepatitis C Clinical Trial using LDV/SOF FDC; SOF; RBV; PEG; GS-9669; GS-5816

Gilead Sciences - Recruiting 18 years or older.
- A Phase 2, Multicenter, Open-Label Study to Assess the Efficacy and Safety of Sofosbuvir Containing Regimens for the Treatment of Chronic HCV Infection.
LDV/SOF FDC; SOF; RBV; PEG; GS-9669; GS-5816

Post Operative Surgical Site Infection Clinical Trial using Supplemental Perioperative Oxygen

Major Extremity Trauma Research Consortium - Recruiting 18 years to 80 years.
- Supplemental Perioperative Oxygen to Reduce Surgical Site Infection After High Energy Fracture Surgery (OXYGEN Study).
Supplemental Perioperative Oxygen

Hepatitis C Clinical Trial using MK-5172; MK-8742; Placebo; Ribavirin

Merck Sharp & Dohme Corp. - Recruiting 18 years or older.
- A Phase II Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen MK-5172 and MK-8742 ñ Ribavirin (RBV) in Subjects With Chronic Hepatitis C Virus Infection.
MK-5172; MK-8742; Placebo; Ribavirin

Job's Syndrome Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting N/A or older.
- Natural History, Management, and Genetics of the Hyperimmunoglobulin E Recurrent Infection Syndrome (HIES).

BSI Due to CRE, or Nosocomial Pneumonia Due to CRE Clinical Trial using plazomicin; colistin; meropenem; tigecycline

Achaogen, Inc. - Recruiting 18 years to 85 years.
- A Phase 3, Multicenter, Randomized, Open-Label Study to Evaluate the Efficacy and Safety of Plazomicin Compared With Colistin in Patients With Infection Due to Carbapenem-Resistant Enterobacteriaceae (CRE).
plazomicin; colistin; meropenem; tigecycline

Anal Cancer, Nonneoplastic Condition, Penile Cancer, or Precancer Clinical Trial using quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine; laboratory biomarker analysis

AIDS Malignancy Clinical Trials Consortium - Recruiting 13 years to 26 years.
- AMC-072: Protective Effect of Quadrivalent Vaccine in Young HIV-Positive Males Who Have Sex With Males.
quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine; laboratory biomarker analysis

Cystic Fibrosis Clinical Trial using Aztreonam for Inhalation Solution (AZLI); Placebo

Gilead Sciences - Recruiting 6 years or older.
- A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy (CAT) Regimen of Inhaled Antibiotics for the Treatment of Chronic Pulmonary Pseudomonas Aeruginosa Infection in Subjects With Cystic Fibrosis.
Aztreonam for Inhalation Solution (AZLI); Placebo

Hepatitis C, Chronic Clinical Trial using Faldaprevir; BI 207127; BI 207127 high dose; Ribavirin placebo; BI 207127 high dose placebo; Ribavirin; Faldaprevir placebo; BI 207127 low dose; BI 207127 low dose placebo

Boehringer Ingelheim - Recruiting 18 years to 75 years.
- A Phase III Randomised, Double-blind and Placebo-controlled Study of BI 207127 in Combination With Faldaprevir and Ribavirin in Patients With Moderate Hepatic Impairment (Child-Pugh B) With Genotype 1b Chronic Hepatitis C Infection.
Faldaprevir; BI 207127; BI 207127 high dose; Ribavirin placebo; BI 207127 high dose placebo; Ribavirin; Faldaprevir placebo; BI 207127 low dose; BI 207127 low dose placebo

Filariasis, Helminthiasis, Loiasis, Mansonelliasis, or Onchocerci Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 1 year or older.
- Host Response to Infection and Treatment in the Filarial Diseases of Humans.

Staphylococcal Aureus Infection, Recurrent Staphylococcal Infecti Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 2 years or older.
- Host Factors in Invasive and Recurrent Staphylococcus Aureus Infection.

Nontuberculous Mycobacterial Infection Clinical Trial using Sildenafil

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Sildenafil in Patients With Pulmonary Nontuberculous Mycobacterial Infection.
Sildenafil

Primary Immune Deficiency, Candida, Autoimmune Polyendocrinopathy Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting N/A or older.
- Studies of Disorders With Increased Susceptibility to Fungal Infections.

Respiratory Syncytial Virus, or Asthma Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years to 60 years.
- The Role of TGF-Beta in Asthmatic Epithelial Cell Susceptibility to RSV Infection.

HCV Infection Clinical Trial using Sofosbuvir; RBV

Gilead Sciences - Recruiting 18 years or older.
- A Phase 2b, Open-Label Study of 200 mg or 400 mg Sofosbuvir+RBV for 24 Weeks in Genotype 1 or 3 HCV-Infected Subjects With Renal Insufficiency.
Sofosbuvir; RBV

Herpes Genitalis, Herpes Simplex Virus, Herpes Simplex Virus Vacc Clinical Trial using Injection; Blood Draw; Clinical evaluation of herpes simplex diseases; Self swabbing for asymptomatic viral shedding; Collection of cervicovaginal secretions

National Institutes of Health Clinical Center (CC) - Recruiting 18 years to 40 years.
- Phase I Study of the Safety of Replication-Defective Herpes Simplex Virus-2 Vaccine, HSV529, in Adults Aged 18 to 40 Years With or Without HSV Infection.
Injection; Blood Draw; Clinical evaluation of herpes simplex diseases; Self swabbing for asymptomatic viral shedding; Collection of cervicovaginal secretions

Infection, Cancer, Neoplasm, Empyema, or Granuloma Clinical Trial using Xperguide CT; Electromagnetic Tracking; Computed Tomography

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Prospective Randomized Trial Comparing Navigation With Xperguide vs. Conventional Methods During Percutaneous Image Guided Procedures.
Xperguide CT; Electromagnetic Tracking; Computed Tomography

Immunologic Deficiency Syndrome, or Infection Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting N/A or older.
- Detection and Characterization of Host Defense Defects.

Chagas Disease, Malaria, Parasitic Disease, or Trypanosomiasis Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 1 year to 85 years.
- Evaluation, Treatment, and Monitoring of Patients With Known or Suspected Parasitic Infection.

HIV, or Therapeutic Vaccine Clinical Trial using HIV-1 Multiantigen pDNA Vaccine; Human IL-12 pDNA; In Vivo Electroporation using the TriGri; rVSVIN HIV Gag Vaccine; Placebo

National Institutes of Health Clinical Center (CC) - Recruiting 18 years to 65 years.
- A Phase I Randomized, Double-Blind, Placebo-Controlled Study of a Multi-Antigen DNA Vaccine Prime Delivered by In Vivo Electroporation, rVSV Booster Vaccine in HIV-Infected Patients Who Began Antiretroviral Therapy During Acute/Early Infection.
HIV-1 Multiantigen pDNA Vaccine; Human IL-12 pDNA; In Vivo Electroporation using the TriGri; rVSVIN HIV Gag Vaccine; Placebo

Lyme Disease, or Borrelia Burgdorferi Clinical Trial using Skin Biopsy; Xenodiagnosis; Blood Drawing

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Searching for Persistence of Infection in Lyme Disease.
Skin Biopsy; Xenodiagnosis; Blood Drawing

UCD, MMA, Acidemias, or Fatty Acid Oxidation Defects Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 2 years or older.
- The NIH Mini Study: Metabolism, Infection and Immunity in Inborn Errors of Metabolism.

Pneumocystis Pneumonia Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 3 years or older.
- Studies of Human Pneumocystis Infection.

Chronic Disease, Healthy, Lyme Arthritis, Lyme Disease, or Multip Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 13 years or older.
- A Comprehensive Clinical, Microbiological and Immunological Assessment of Patients With Suspected Chronic Lyme Infection and Selected Control Populations.

HIV Infection, or Kaposi's Sarcoma Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With HIV Infection, KSHV Infection, Viral-Related Pre-Malignant Lesions, and/or Cancer.

HIV Infections, AIDS, or Opportunistic Infections Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Clinical and Immunologic Monitoring of Patients With Known or Suspected HIV Infection.

Invasive Fungal Infection Clinical Trial using Micafungin

Nantes University Hospital - Recruiting 18 years to 65 years.
- Antifungal Prophylaxis With Micafungin After Cord Blood Allogeneic Stem Cell Transplantation.
Micafungin

HIV Infection, or Neoplasm Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 7 years to 17 years.
- Psychological Benefits of a Normalized Camping Experience for Children With Cancer.

Loiasis Clinical Trial using Reslizumab; Diethylcarbamazine

National Institutes of Health Clinical Center (CC) - Recruiting 18 years to 65 years.
- A Randomized, Placebo-controlled, Double-Blind Pilot Study of Single-Dose Humanized Anti-IL5 Antibody (Reslizumab) for the Reduction of Eosinophilia Following Diethylcarbamazine Treatment of Loa Loa Infection.
Reslizumab; Diethylcarbamazine

Idiopathic Bronchiectasis, or Nontuberculous Mycobacterium (NTM) Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Cross-Sectional Characterization of Idiopathic Bronchiectasis.

Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficie Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 14 years or older.
- Characterization and Management of Patients With HIV-1 Infection Who Experience Virologic Failure Despite Combination Antiretroviral Therapy.

Tuberculosis, HIV, or IRIS Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Transcriptional Signature of HIV And TB Co-Infection.

Parainfluenza Infection Clinical Trial using DAS181; Placebo

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- A Randomized, Double-Blind, Placebo-Controlled Phase II Study of DAS181 in Patients With Parainfluenza Infection.
DAS181; Placebo

Gonococcal (GC) Infection Clinical Trial using Part A; Part B; Part C

AstraZeneca - Recruiting 18 years to 55 years.
- A Phase I, Randomized, Placebo-controlled, Single Center Study to Assess the Safety, Tolerability, and Pharmacokinetic of AZD0914 After Oral Administration of Single Doses or Multiple Doses Over 24 Hours and to Assess the Effect of Food in Healthy Adult Volunteers.
Part A; Part B; Part C

Urinary Tract Infection, or Leiomyoma Clinical Trial

The Cleveland Clinic - Recruiting 18 years or older.
- Lower UTI Evaluation in Women With Uterine Leiomyomata.

Influenza Clinical Trial using oseltamivir [Tamiflu]

Hoffmann-La Roche - Recruiting N/A to 12 years.
- AN OPEN-LABEL, RANDOMIZED, ADAPTIVE, TWO-ARM, MULTICENTER TRIAL TO EVALUATE PHARMACOKINETICS AND PHARMACODYNAMICS OF TWO DOSES OF OSELTAMIVIR (TAMIFLUr) IN THE TREATMENT OF INFLUENZA IN IMMUNOCOMPROMISED CHILDREN, FROM 2 WEEKS TO LESS THAN 13 YEARS OF AGE, WITH CONFIRMED INFLUENZA INFECTION.
oseltamivir [Tamiflu]

Clostridium Difficile Infection Clinical Trial using CB-183,315; oral vancomycin

Cubist Pharmaceuticals - Recruiting 18 years to 90 years.
- A Randomized, Double-Blinded, Active-Controlled Study of CB-183,315 in Patients With Clostridium Difficile Associated Diarrhea.
CB-183,315; oral vancomycin

Bacterial Infections Clinical Trial using Solithromycin

Cempra Pharmaceuticals - Recruiting 12 years to 17 years.
- A Phase 1, Open-label, Multi-center Study to Determine the PK and Safety of Solithromycin as Add-on Therapy in Adolescents With Suspected or Confirmed Bacterial Infection.
Solithromycin

Transplant Recipients With CMV Infection Clinical Trial using CMV Infection

University Hospital, Limoges - Recruiting N/A or older.
- A French Cohort of Transplant Recipients With CMV Infection : Risk Factors for Antiviral Resistance in the Prophylaxis Era. Survey of Pharmacological and Virological Resistance of Cytomegalovirus to Antiviral Therapy in Transplantation..
CMV Infection

Clostridium Difficile Infection Clinical Trial using CB-183,315; oral vancomycin

Cubist Pharmaceuticals - Recruiting 18 years to 90 years.
- A Randomized, Double-Blinded, Active-Controlled Study of CB-183,315 in Patients With Clostridium Difficile Associated Diarrhea.
CB-183,315; oral vancomycin

Lower Extremity Surgery, Surgical Site Infection, Bacterial Colon Clinical Trial using Chloraprep

Sanford Health - Recruiting 18 years or older.
- Role of Post-operative Re-application of Chloraprepr Following Lower Extremity Surgeries on Surgical Site Bacterial Colonization..
Chloraprep

Respiratory Tract Infection Clinical Trial using Respiratory Inductive Plethysmography

National Institute of Allergy and Infectious Diseases (NIAID) - Recruiting N/A to 3 years.
- Impact of Respiratory Virus Infections and Bacterial Microbiome Shifts on Lymphocyte and Respiratory Function in Infants Born Prematurely or Full Term.
Respiratory Inductive Plethysmography

Pneumonia, Pneumococcal Infection, or Pathogen Resistance Clinical Trial using Colistimethate (Colistin)Sodium-Intravenous; Colistimethate (Colistin)Sodium-Aerosolized

National Institute of Allergy and Infectious Diseases (NIAID) - Recruiting 18 years to 45 years.
- A Phase 1, Open-Labeled Study of the Safety, Tolerability and Pharmacokinetics of Aerosolized Colistimethate Sodium After Multiple Doses Administered Separately or in Combination With Intravenous Colistimethate Sodium in Healthy Adults.
Colistimethate (Colistin)Sodium-Intravenous; Colistimethate (Colistin)Sodium-Aerosolized

Skin Diseases, Infectious Clinical Trial using Tedizolid(BAY1192631); Linezolid

Bayer - Recruiting 20 years or older.
- A Prospective, Randomized, Open-label, Active-controlled, Multicenter Study to Evaluate the Efficacy and Safety of BAY 1192631 in Japanese Patients With MRSA Infections (Skin and Soft Tissue Infection [SSTI] and SSTI-related Bacteremia).
Tedizolid(BAY1192631); Linezolid

Shigella Infection Clinical Trial using Placebo; WRSs2; WRSs3

National Institute of Allergy and Infectious Diseases (NIAID) - Recruiting 18 years to 45 years.
- Safety and Immunogenicity of Two Live, Attenuated Oral Shigella Sonnei Vaccines: WRSs2 and WRSs3.
Placebo; WRSs2; WRSs3

Arrhythmia Clinical Trial using Incremental; Conventional

Population Health Research Institute - Recruiting 18 years or older.
- Prevention of Arrhythmia Device Infection Trial (PADIT) Cluster Crossover Study.
Incremental; Conventional

Streptococcus Pneumoniae Infection, or Pneumococcal Infections Clinical Trial using V114; Prevnar 13

Merck Sharp & Dohme Corp. - Recruiting 2 Months to 49 years.
- A Phase I-II, Randomized, Double-Blind, Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 in Healthy Adults and Infants.
V114; Prevnar 13

Infection Prevention Clinical Trial using Cefazolin

Women and Infants Hospital of Rhode Island - Recruiting N/A or older.
- PROPHYLACTIC ANTIBIOTICS PRIOR TO CESAREAN SECTION IN OBESE WOMEN: Does Increasing the Dose Increase the Tissue Concentration?.
Cefazolin

Hepatitis C Clinical Trial using DCV/ASV/BMS-791325

Bristol-Myers Squibb - Recruiting 18 years or older.
- A Phase 3 Evaluation of a Daclatasvir/Asunaprevir/BMS-791325 Fixed Dose Combination in Non-cirrhotic Subjects With Genotype 1 Chronic Hepatitis C.
DCV/ASV/BMS-791325

Cure Rate Clinical Trial using KAE609

Novartis - Recruiting 20 years to 60 years.
- An Open Label, Single Dose Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of KAE609 in Adult Patients With Acute, Uncomplicated Plasmodium Falciparum Malaria Mono-infection.
KAE609

Chronic HCV Infection Clinical Trial using LDV/SOF; RBV

Gilead Sciences - Recruiting 18 years or older.
- A Phase 2, Multicenter, Open-Label Study to Investigate the Safety and Efficacy of Sofosbuvir/Ledipasvir Fixed-Dose Combination + Ribavirin Administered in Subjects Infected With Chronic HCV Who Have Advanced Liver Disease or Are Post-Liver Transplant.
LDV/SOF; RBV

HIV Infection Clinical Trial using Hydroxychloroquine

St Stephens Aids Trust - Recruiting 18 years to 65 years.
- The Immunological Impact of Adding Hydroxychloroquine in Patients With Discordant CD4+ Cell Responses to Suppressive HAART: A Phase I Pilot Study..
Hydroxychloroquine

Chronic Hepatitis C Infection Clinical Trial using JNJ-47910382 30 mg; JNJ-47910382 90 mg; JNJ-47910382 200 mg; Placebo

Janssen R&D Ireland - Recruiting 18 years to 70 years.
- A Phase Ib, Randomized, Double-Blind, Placebo-Controlled Trial in Asian Genotype 1 Chronic HCV-Infected Subjects to Determine the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of Repeated Doses of JNJ-47910382 Given in Different Doses and Dose Regimens.
JNJ-47910382 30 mg; JNJ-47910382 90 mg; JNJ-47910382 200 mg; Placebo

Infection, Skin and Subcutaneous Tissue Bacterial Infections, Hea Clinical Trial

Denver Health and Hospital Authority - Recruiting 18 years or older.
- Rapid Microbiological Diagnostics for MDRO Quantitative Identification and Resistance Phenotyping to Guide Antibiotic Selection in Wounded Warriors and Veterans.

Dengue Fever Clinical Trial using CLEC5A

Kaohsiung Medical University Chung-Ho Memorial Hospital - Recruiting N/A or older.
- Follow-up the Health Condition , Investigation of the Immuno-regulation , and the Study for Interaction of Viral Hepatitis--- Among Patients With or After Dengue Fever Infection.
CLEC5A

Pulmonary Nontuberculous Mycobaterium Infection Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Comparing Expectorated and Induced Sputum and Pharyngeal Swabs for Cultures, AFB Smears, and Cytokines in Pulmonary Nontuberculous Mycobacterial Infection.

Cancer, HIV Infection, or Skin Disease Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting N/A or older.
- Eligibility Screening and Tissue Procurement for the National Cancer Institute (NCI) Center for Cancer Research (CCR) Clinical Protocols.

Blood And Marrow Transplantation, Leukemia, Lymphoma, Transplanta Clinical Trial using Melphalan; Fludarabine; Mycophenolate mofetil; Tacrolimus; Cord Blood Infusion; Rituximab; ATG; Busulfan; Clofarabine; Total Body Irradiation (TBI)

M.D. Anderson Cancer Center - Recruiting 1 year to 80 years.
- Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies.
Melphalan; Fludarabine; Mycophenolate mofetil; Tacrolimus; Cord Blood Infusion; Rituximab; ATG; Busulfan; Clofarabine; Total Body Irradiation (TBI)

Surgical Wound Infection Clinical Trial using Cefazolin; Placebo

Rabin Medical Center - Recruiting 18 years or older.
- Antibiotic Prophylaxis for Revision, Clean Head and Neck Surgery.
Cefazolin; Placebo

Bloodstream Infection Due to Central Venous Catheter Clinical Trial

Medical University of Graz - Recruiting 18 years or older.
- Anticipative Diagnosis of Central Venous Catheter Related Bloodstream Infections Using Biphasic PNA FISH and Gram Stain/AOLC Tests.

Parkinson's Disease, or HIV Infections Clinical Trial

KineMed - Recruiting 18 years or older.
- Cellular and Molecular Kinetics of Cerebrospinal Fluid (CSF) Using Heavy Water Labeling Method: A Study of Healthy Controls, CNS HIV Infection, Parkinson's Disease and Other Neurodegenerative Diseases.

Acute Leukemias of Ambiguous Lineage, Bacterial Infection, Diarrh Clinical Trial using levofloxacin

Children's Oncology Group - Recruiting 6 Months to 21 years.
- A Randomized Trial of Levofloxacin to Prevent Bacteremia in Children Being Treated for Acute Leukemia (AL) or Undergoing Hematopoietic Stem Cell Transplantation (HSCT).
levofloxacin

Hepatitis C Infection, or Thrombocytopenia Clinical Trial using romiplostim; ribavirin; placebo; PEG-interferon alfa-2a; laboratory biomarker analysis

University of Southern California - Recruiting 18 years or older.
- A Double-Blind, Placebo-controlled Phase II Study to Assess the Efficacy and Safety of Romiplostim, Administered Once Weekly to Thrombocytopenic Hepatitis C (HCV) Infected Subjects Who Are Not Candidates for Antiviral Treatment With Pegylated Interferon and Ribavirin Due to Persistent Thrombocytopenia.
romiplostim; ribavirin; placebo; PEG-interferon alfa-2a; laboratory biomarker analysis

Symptomatic Urinary Tract Infection, or Spinal Cord Injury Clinical Trial using individual homeopathic treatment; standard treatment without homeopathy

Swiss Paraplegic Centre Nottwil - Recruiting 18 years to 90 years.
- Clinical Value of Homeopathic Assessment and Treatment for Prophylaxis of Recurrent Urinary Tract Infections in Persons With Spinal Cord Injury.
individual homeopathic treatment; standard treatment without homeopathy

Pseudomonas Aeruginosa Infection Clinical Trial using IC43; Placebo

Valneva Austria GmbH - Recruiting 18 years to 80 years.
- A Confirmatory Phase II/III Study Assessing Efficacy, Immunogenicity and Safety of IC43 Recombinant Pseudomonas Vaccine Intensive Care Patients.
IC43; Placebo

Hepatitis C, Chronic, or Human Immunodeficiency Virus Clinical Trial using DAA against HCV

Valme University Hospital - Recruiting 18 years or older.
- Security and Efficacy of Triple Therapy Including Direct-Acting Antivirals Against Chronic Hepatitis C Infection In HIV-Coinfected Patients In Real-Life Conditions: The Prospective HEPAVIR Cohort..
DAA against HCV

Congenital Combined Immunodeficiency, Fungal Infection, Hematopoi Clinical Trial using caspofungin acetate; fluconazole; voriconazole; laboratory biomarker analysis

Children's Oncology Group - Recruiting N/A to 20 years.
- A Phase III Open-Label Trial of Caspofungin vs. Azole Prophylaxis for Patients at High-Risk for Invasive Fungal Infections (IFI) Following Allogeneic Hematopoietic Cell Transplantation (HCT).
caspofungin acetate; fluconazole; voriconazole; laboratory biomarker analysis

Papillomavirus Infections, or HIV Infections Clinical Trial using Oral swabs for HPV-typing and high-risk HPV-determination

Deutsche Luft und Raumfahrt - Recruiting 18 years or older.
- Incidence, Prevalence, Spectrum of HPV-types, and Viral Load Determination of High-risk Human Papillomavirus Infection of the Oral Cavity in HIV-infected Men Who Have Sex With Men.
Oral swabs for HPV-typing and high-risk HPV-determination

HIV Infection Clinical Trial using 3MV; PCC; Emtricitabine/tenofovir (FTC/TDF (Truvadar))

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) - Recruiting 15 years to 17 years.
- Project PrEPare - An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among 15 to 17 Year Old Young Men Who Have Sex With Men (YMSM) in the United States.
3MV; PCC; Emtricitabine/tenofovir (FTC/TDF (Truvadar))

Heart Diseases, or HIV Clinical Trial

University Hospital, Bonn - Recruiting 18 years or older.
- Myocardial T1-mapping and T1-derived Extracellular Volume Fraction (ECV) in HIV-infection Patients With Chronic High and Low CD4+ Counts and in a Healthy Control Group.

Colostomy Clinical Trial using Pursestring Wound Closure; Gunsight Skin Incision and Closure Technique

Beijing Chao Yang Hospital - Recruiting N/A or older.
- Randomized Clinical Trial of Stoma Reversal Comparing Pursestring Wound Closure vs 'Gunsight' Skin Incision and Closure Technique to Eliminate the Risk of Wound Infection.
Pursestring Wound Closure; Gunsight Skin Incision and Closure Technique

Bone Marrow Transplant Infection, Infection in Marrow Transplant Clinical Trial using Ribavirin

M.D. Anderson Cancer Center - Recruiting 18 years or older.
- An Open Label Randomized Controlled Trial To Prevent the Progression of Respiratory Syncytial Virus Upper Respiratory Tract Infection to Lower Respiratory Tract Infection in Patients After Hematopoietic Stem Cell Transplant.
Ribavirin

Respiratory Infection Clinical Trial using Respiratory infection

Universidad de Granada - Recruiting 50 years or older.
- Repercussion of Hospital Stay in Patients With Respiratory Infection.
Respiratory infection

Radiofrequency Ablation, Liver Abscesses -Staphylococcus Infectio Clinical Trial using RFA - Radiofrequency Ablation; Scans - Liver; Liver; Drawn

National Institutes of Health Clinical Center (CC) - Recruiting 18 years to 75 years.
- Radiofrequency Ablation (RFA) for the Treatment of Liver Abscesses in Patients With Chronic Granulomatous Disease.
RFA - Radiofrequency Ablation; Scans - Liver; Liver; Drawn

Carcinoma, Squamous Cell, Head and Neck Neoplasms, or Oropharynge Clinical Trial using Assessment of Oral HPV Infection

UNC Lineberger Comprehensive Cancer Center - Recruiting 18 years or older.
- Monitoring of Oral HPV Infection in HPV-positive Oropharyngeal Squamous Cell Carcinoma During and After Chemoradiotherapy (CRT).
Assessment of Oral HPV Infection

Complicated Skin and Soft Tissue Infection Clinical Trial using Ceftaroline fosamil; Vancomycin; Aztreonam

AstraZeneca - Recruiting 18 years or older.
- A Phase III, Multicentre, Randomised, Double-Blind Comparative Study to Evaluate the Efficacy and Safety of Ceftaroline Fosamil (600 mg Every 8 Hours) Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Complicated Bacterial Skin and Soft Tissue Infections With Evidence of Systemic Inflammatory Response or Underlying Comorbidities.
Ceftaroline fosamil; Vancomycin; Aztreonam

Chronic HCV Infection Clinical Trial using Sofosbuvir; RBV

Gilead Sciences - Recruiting 18 years or older.
- A Phase 3b, Multicenter, Open-Label, Randomized Study to Investigate the Efficacy and Safety of Sofosbuvir Plus Ribavirin in Treatment-Naive Subjects With Chronic Genotype 1, 2, 3 and 6 HCV Infection and in Treatment-Experienced Subjects With Chronic Genotype 2 HCV Infection.
Sofosbuvir; RBV

Complicated Intra-Abdominal Infection Clinical Trial using CAZ-AVI; Metronidazole; Meropenem

AstraZeneca - Recruiting 18 years to 90 years.
- A Phase III, Randomized, Multicenter, Double Blind, Double-Dummy, Parallel-Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam Plus Metronidazole Versus Meropenem in the Treatment of Complicated Intra-Abdominal Infections In Hospitalized Adults.
CAZ-AVI; Metronidazole; Meropenem

Surgical Site Infection Clinical Trial using Early administration of SAP (Cefuroxime (plus metronidazole in colorectal surgery)) early in anesthetic room (75 to 30 minutes prior to skin incision); Late administration of SAP (Cefuroxime (plus metronidazole in colorectal surgery)) in the operating theatre (within 30 minutes prior to skin incision)

University Hospital, Basel, Switzerland - Recruiting 18 years or older.
- Randomized Controlled Trial to Evaluate the Optimal Timing of Surgical Antimicrobial Prophylaxis.
Early administration of SAP (Cefuroxime (plus metronidazole in colorectal surgery)) early in anesthetic room (75 to 30 minutes prior to skin incision); Late administration of SAP (Cefuroxime (plus metronidazole in colorectal surgery)) in the operating theatre (within 30 minutes prior to skin incision)

Chronic HCV Infection Clinical Trial using SOF/LDV FDC; RBV

Gilead Sciences - Recruiting 18 years or older.
- A Phase 2, Multicenter, Open-Label Study to Investigate the Safety and Efficacy of Sofosbuvir/Ledipasvir Fixed-Dose Combination + Ribavirin Administered in Subjects Infected With Chronic HCV Who Have Advanced Liver Disease or Are Post-Liver Transplant.
SOF/LDV FDC; RBV

Treatment of H Pylori Infection Clinical Trial using Pylera based reduced regimen

American University of Beirut Medical Center - Recruiting 18 years to 80 years.
- AN OPEN-LABEL TRIAL OF REDUCED- DOSE PYLERA (BISMUTH, METRONIDAZOLE, TETRACYCLINE), AMOXICILLIN, AND ESOMEPRAZOLE IN THE TREATMENT OF HELICOBACTER PYLORI INFECTION.
Pylera based reduced regimen

Hepatitis C Clinical Trial using MK-5172; MK-8742; Ribavirin

Merck Sharp & Dohme Corp. - Recruiting 18 years or older.
- A Phase II Clinical Trial to Study the Efficacy and Safety of a Combination Regimen of MK-5172 and MK-8742 With Ribavirin (RBV) in Subjects With Chronic Hepatitis C Genotype 2 Infection.
MK-5172; MK-8742; Ribavirin

Hepatitis C Virus Clinical Trial using Pegylated-Interferon-lambda; Ribavirin; Daclatasvir

Bristol-Myers Squibb - Recruiting 18 years or older.
- A Phase 3 Study Evaluating the Safety and Efficacy of Lambda/Ribavirin/Daclatasvir in Subjects With Chronic HCV Infection and Underlying Hemophilia Who Are Treatment Na‹ve or Are Prior Relapsers to Peginterferon Alfa-2a/Ribavirin.
Pegylated-Interferon-lambda; Ribavirin; Daclatasvir

Sepsis Clinical Trial

Hopital Saint Roch - Recruiting 18 years or older.
- Lactate and Sepsis : What Dosage Use as Triage Tool in Emergency Department for Patients With Suspected Infection..

HIV Infection Clinical Trial using Micronutrients and antioxidants; Multivitamins and minerals

Ottawa Hospital Research Institute - Recruiting 18 years or older.
- A Randomized Control Clinical Trial Of Micronutrient & Antioxidant Supplementation in Persons With Untreated HIV Infection.
Micronutrients and antioxidants; Multivitamins and minerals

Cytomegalovirus Infection, or Healthy, no Evidence of Disease Clinical Trial using multi-CMV epitope modified vaccinia Ankara vaccine; laboratory biomarker analysis

City of Hope Medical Center - Recruiting 18 years to 50 years.
- Phase I Evaluation of a CMV-MVA Triplex Vaccine: Safety and Biologically Effective Dose in Healthy Volunteers With or Without Prior Immunity to CMV and Vaccinia.
multi-CMV epitope modified vaccinia Ankara vaccine; laboratory biomarker analysis

Chlamydia Trachomatis Infection in Pregnancy Clinical Trial using Amoxicillin; Erythromycin

Obafemi Awolowo University Teaching Hospital - Recruiting N/A or older.
- Erythromycin Versus Amoxicillin for Treatment of Antenatal Chlamydia Trachomatis Infection: A Randomized Controlled Trial.
Amoxicillin; Erythromycin

HIV Infection, Monoclonal Antibody, Human, HIV Antibodies, VRC01 Clinical Trial using VRC-HIVMAB060-00-AB

National Institutes of Health Clinical Center (CC) - Recruiting 18 years to 50 years.
- VRC 602: A Phase 1 Dose-Escalation Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIV MAB060-00-AB (VRC01),Administered Intravenously or Subcutaneously to Healthy Adults.
VRC-HIVMAB060-00-AB

Ebola Virus Infection Clinical Trial using TKM-100802 for Injection; Placebo

Tekmira Pharmaceuticals Corporation - Recruiting 18 years to 50 years.
- A Placebo-Controlled, Single-Blind, Single-Ascending Dose Study With Additional Multiple-Ascending Dose Cohorts to Evaluate the Safety, Tolerability, and Pharmacokinetics of TKM-100802 in Healthy Human Volunteers.
TKM-100802 for Injection; Placebo

Complicated Urinary Tract Infection (cUTI) Including Acute Pyelon Clinical Trial using CAZ-AVI; Doripenem; Either switch to oral therapy: 500 mg of Ciprofloxacin (oral); or switch to oral therapy: 800 mg/160 mg of sulfamethoxazole/trimethoprim (oral)

AstraZeneca - Recruiting 18 years to 90 years.
- A Phase III, Randomized, Multicenter, Double-Blind, Double Dummy, Parallel Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam (CAZ-AVI, Formerly CAZ104) Versus Doripenem Followed by Appropriate Oral Therapy in the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis, With a Gram Negative Pathogen in Hospitalized Adults.
CAZ-AVI; Doripenem; Either switch to oral therapy: 500 mg of Ciprofloxacin (oral); or switch to oral therapy: 800 mg/160 mg of sulfamethoxazole/trimethoprim (oral)

Complicated Intra-Abdominal Infection Clinical Trial using CAZ-AVI; Metronidazole; Meropenem

AstraZeneca - Recruiting 18 years to 90 years.
- A Phase III, Randomized, Multicenter, Double Blind, Double-Dummy, Parallel-Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam Plus Metronidazole Versus Meropenem in the Treatment of Complicated Intra-Abdominal Infections In Hospitalized Adults.
CAZ-AVI; Metronidazole; Meropenem

Infections, Cytomegalovirus Clinical Trial using Blood collection; Urine collection; Dry urine collection; Saliva collection; Urine and/ or saliva collection from newborn in case of pregnancy

GlaxoSmithKline - Recruiting 10 years to 17 years.
- A Study in Adolescent Females to Explore Cytomegalovirus Infection.
Blood collection; Urine collection; Dry urine collection; Saliva collection; Urine and/ or saliva collection from newborn in case of pregnancy

Hepatitis C Clinical Trial using ABT-450/ritonavir; ABT-333; ABT-267

AbbVie - Recruiting 18 years to 80 years.
- A Follow-up Study to Assess Resistance and Durability of Response to AbbVie Direct-Acting Antiviral Agent (DAA) Therapy in Subjects Who Participated in Phase 2 or 3 Clinical Studies for the Treatment of Chronic Hepatitis C Virus (HCV) Infection.
ABT-450/ritonavir; ABT-333; ABT-267

Malaria Clinical Trial using KAF156 400 mg; KAF156 800 mg

Novartis - Recruiting 20 years to 60 years.
- A Proof-of-concept, Open Label Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of KAF156 in Adult Patients With Acute, Uncomplicated Plasmodium Falciparum or Vivax Malaria Mono-infection.
KAF156 400 mg; KAF156 800 mg

Hepatitis C, Chronic Clinical Trial using VGX-6150

VGX International, Inc. - Recruiting 19 years to 65 years.
- Multi-center, Open-label, Dose Escalation, Phase I Trial to Evaluate the Safety, Tolerability and Immunogenicity of VGX-6150 for Second-line Therapy of Chronic Hepatitis C Infection.
VGX-6150

Clostridium Difficile Infection Clinical Trial using Human fecal matter

Englewood Hospital and Medical Center - Recruiting 18 years or older.
- Fecal Microbiota Transplantation for the Treatment of Recurrent or Refractory Clostridium Difficile Infection (CDI).
Human fecal matter

HBV Infection Clinical Trial

Southwest Hospital, China - Recruiting 18 years to 65 years.
- The Effect of General Anesthesia Immunosuppressive on Hepatitis B Virus Replication.

Atherosclerosis Clinical Trial

University of California, San Francisco - Recruiting 18 years to 65 years.
- Immunologic and Inflammatory Factors and Cardiovascular Risk in Patients With HIV Infection or Autoimmune Diseases.

HIV Infection Clinical Trial

Merck Sharp & Dohme Corp. - Recruiting 3 years or older.
- Re-examination Study for General Drug Use to Assess the Safety and Efficacy Profile of STOCRIN in Usual Practice.

Insulin Resistance Clinical Trial

University of California, San Francisco - Recruiting 18 years to 60 years.
- Impact of Hepatitis C on Insulin Sensitivity and Insulin Secretion in Latinos.

HIV-1 Infection Clinical Trial

Gen-Probe, Incorporated - Recruiting 15 years or older.
- Collection of Plasma Samples From Human Immunodeficiency Virus (HIV) Type 1 (HIV-1) Infected Individuals for the Clinical Evaluation of the Aptima HIV-1 Quant Dx Assay.

HIV-1 Infection Clinical Trial using Vorinostat

University of North Carolina, Chapel Hill - Recruiting 18 years to 65 years.
- A Phase I/II Investigation of the Effect of Vorinostat (VOR) on HIV RNA Expression in the Resting CD4+ T Cells of HIV-Infected Patients Receiving Stable Antiretroviral Therapy.
Vorinostat

Cervical Adenocarcinoma, Cervical Squamous Cell Carcinoma, Human Clinical Trial using ipilimumab; laboratory biomarker analysis

National Cancer Institute (NCI) - Recruiting 18 years or older.
- A Phase 2 Study of Ipilimumab in Women With Metastatic or Recurrent HPV-Related Cervical Carcinoma of Either Squamous Cell or Adenocarcinoma Histologies.
ipilimumab; laboratory biomarker analysis

HIV Infection, Cardiovascular Disease, or Inflammation Clinical Trial

University of California, San Francisco - Recruiting 40 years to 80 years.
- The Role of Inflammation and Aging in HIV-Associated Cardiovascular Risk.

HIV Clinical Trial using VAC-3S

InnaVirVax - Recruiting 18 years to 60 years.
- Assessment of the Therapeutic Properties of the VAC-3S Immunoprotective Vaccine When Combined With Standard Antiretroviral Therapy (ART) in the Course of HIV-1 Infection. A European, Randomized, Double Blind Placebo-controlled Phase II Study.
VAC-3S

HCV Infection Clinical Trial using MK-8876 200 mg or ó800 mg

Merck Sharp & Dohme Corp. - Recruiting 18 years to 65 years.
- A Multiple Dose Study to Evaluate Safety, Pharmacokinetics and Pharmacodynamics of MK-8876 in Hepatitis C Patients.
MK-8876 200 mg or ó800 mg

Hepatitis C Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Epidemiology, Infectivity and Natural History of Hepatitis C Virus Infection in a Blood Donor Population.

Immune Disorders, Chronic Granulomatous Disease, Genetic Immunolo Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting N/A or older.
- Screening Protocol for Detection and Characterization of Infections and Infection Susceptibility.

HIV Infection Clinical Trial using Bruthas Project; Standard HIV Testing and Counseling

University of California, San Francisco - Recruiting 18 years to 65 years.
- A Randomized Controlled Trial of the Bruthas Project.
Bruthas Project; Standard HIV Testing and Counseling

Clostridium Difficile Infection Clinical Trial using Clostridium difficile Toxoid Vaccine; 0.9% normal saline

Sanofi - Recruiting 40 years to 75 years.
- Safety and Immunogenicity of a Clostridium Difficile Toxoid Vaccine Administered to Healthy Adult Subjects Aged 40 to 75 Years in Japan.
Clostridium difficile Toxoid Vaccine; 0.9% normal saline

HIV Infection Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Studies of the Pathogenesis of HIV Infection in Human Peripheral Blood Cells and/or Reproductive Fluids in HIV-Infected and HIV-Uninfected Volunteers.

Chronic Hepatitis B e Antigen Positive, or Chronic Hepatitis B e Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Observational Study of Persons With Hepatitis B Virus Infection in North America (Cohort Study).

HIV-1 Infection Clinical Trial using Part A: lenalidomide dose escalation; Part B: lenalidomide; Part B: lenalidomide placebo

Bionor Immuno AS - Recruiting 18 years to 55 years.
- A Double-blind Placebo Controlled Immunogenicity Study of Vacc-4x + Lenalidomide Versus Vacc-4x With an Initial Open-label Dose Escalation Assessment of Lenalidomide in HIV-1-infected Subjects on Antiretroviral Therapy (ART)..
Part A: lenalidomide dose escalation; Part B: lenalidomide; Part B: lenalidomide placebo

Hepatitis C, Chronic Clinical Trial using Fixed Dose GS-7977/GS-5885; FDC with GS-9451; FDC with GS-9669

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- A Pilot Study to Evaluate the Safety and Efficacy of Multiple Anti-HCV Combination Therapy in Chronically Infected Hepatitis C Patients.
Fixed Dose GS-7977/GS-5885; FDC with GS-9451; FDC with GS-9669

Sensorineural Hearing Loss, or Cytomegalovirus Infection Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting N/A or older.
- Clinical and Molecular Analysis of Enlarged Vestibular Aqueducts.

Hip Prosthetic Joint Infection Clinical Trial using VANCOMYCIN; CEFTRIAXONE; CLINDAMYCIN; SULFAMETHOXAZOLE AND TRIMETHOPRIM (CO-TRIMOXAZOLE); FLUOROQUINOLONE; LINEZOLID; RIFAMPIN

University Hospital, Tours - Recruiting 18 years to 80 years.
- Prospective,Randomized,Open Label,European Multicenter Study of the Efficacy of the Linezolid-rifampin Combination Versus Standard of Care in the Treatment of Gram-positive..
VANCOMYCIN; CEFTRIAXONE; CLINDAMYCIN; SULFAMETHOXAZOLE AND TRIMETHOPRIM (CO-TRIMOXAZOLE); FLUOROQUINOLONE; LINEZOLID; RIFAMPIN

Anticytokine Autoantibody-Associated Diseases, Nontuberculous Myc Clinical Trial using Rituximab intravenous infusions 375 m

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Rituximab (Anti-CD20) for the Treatment of Subjects With Anticytokine Autoantibody-Associated Diseases.
Rituximab intravenous infusions 375 m

Immunodeficiency, Mycobacterial Infection, or Opportunistic Infec Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Mycobacterial and Opportunistic Infections in HIV-Negative Thai and Taiwanese Patients Associated With Autoantibodies to Interferon-gamma.

Chronic Hepatitis C Virus, or Non Alcoholic Fatty Liver Disease Clinical Trial using normocaloric low cholesterol diet

University of Roma La Sapienza - Recruiting 40 years to 70 years.
- Prospective Clinical Study on the Role of the Immune Response, in Relation to Diet, in Patients With Either Chronic Hepatitis C Virus (HCV) Infection or Non Alcoholic Fatty Liver Disease (NAFLD). Director Prof. V. Barnaba, Head of Internal Medicine; Principal Investigator, Prof. C. Balsano.
normocaloric low cholesterol diet

Hepatitis, HIV, or Liver Cancer Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- The Natural History of Liver Disease in a Cohort of Participants With Hepatitis B and/or Hepatitis C With or Without HIV Infection.

Clostridium Difficile Infection Clinical Trial using Rifaximin; Placebo

University of Nottingham - Recruiting 18 years or older.
- A Randomised Placebo Controlled Trial of 'Follow on' Rifaximin for the Prevention of Relapse of Clostridium Associated Diarrhoea.
Rifaximin; Placebo

Meningitis, or Meningococcal Infection Clinical Trial using Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine

Sanofi - Recruiting 9 Months to 17 Months.
- Immunogenicity and Safety of a Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine (Menactrar) in Subjects Aged 9 to 23 Months in India and in the Russian Federation.
Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine

Bacteriuria Clinical Trial using 2 cranberry capsules; Placebo

Yale University - Recruiting 65 years or older.
- A Randomized, Controlled Trial of Cranberry Capsules for UTI Prevention in Nursing Home Residents.
2 cranberry capsules; Placebo

Infection Clinical Trial

Gulhane Military Medical Academy - Recruiting 16 years or older.
- The Microbiologic Profile of Diabetic Foot Infections in Turkey (TURK-DAY): Prospective Multicenter Cohort Study.

HIV Infection Clinical Trial using atazanavir 300mg boosted with ritonavir 50 mg

Ottawa Hospital Research Institute - Recruiting 18 years to 70 years.
- Microboosting of Atazanavir 300 mg With 50 mg Versus 100 mg Ritonavir Daily in HIV-infected Patients: a Pharmacokinetic Study.
atazanavir 300mg boosted with ritonavir 50 mg

Infection Clinical Trial using Hydrogen peroxide pretreatment group

Seoul St. Mary's Hospital - Recruiting 18 years or older.
- Phase 1 Study of Prevention of Cardiac Device Implantation Site Infection.
Hydrogen peroxide pretreatment group

WOUNDS Clinical Trial using Ultrasound debridement; Best practice wound care

Ottawa Hospital Research Institute - Recruiting 18 years or older.
- A Randomized Controlled Trial to Investigate if Application of Low Frequency Ultrasound-assisted Debridement May Improve Healing and Infection Outcomes for the Person With Vasculopathy and Recalcitrant Wounds of the Lower Extremity.
Ultrasound debridement; Best practice wound care

Acute Pyelonephritis Clinical Trial

Institut Investigacio Sanitaria Pere Virgili - Recruiting 2 Months to 14 years.
- Phase 3- Dexamethasone Administration in 1st Episode of Febrile Urinary Tract Infection Episode as Renal Damage Prevention Strategy. DEXCAR.

Chronic Hepatitis C Clinical Trial using Sofosbuvir; RBV; PEG

Gilead Sciences - Recruiting 18 years or older.
- An Open-Label Study of GS-7977 + Ribavirin With or Without Peginterferon Alfa-2a in Subjects With Chronic HCV Infection Who Participated in Prior Gilead HCV Studies.
Sofosbuvir; RBV; PEG

Clinically Suspected H1N1 Infection Clinical Trial

Medical University of Graz - Recruiting N/A or older.
- Influenza A H1N1: Retrospective Analysis of PCR Confirmed Cases of H1N1 Infections in Styria - Risk Factors, Clinical Features and Outcome. Development of a Clinical Score for Suspected H1N1 Infection..

Clostridium Difficile Infection Clinical Trial using C. difficile Toxoid Vaccine; Placebo: 0.9% normal saline

Sanofi - Recruiting 50 years or older.
- Efficacy, Immunogenicity, and Safety Study of Clostridium Difficile Toxoid Vaccine in Subjects at Risk for C. Difficile Infection.
C. difficile Toxoid Vaccine; Placebo: 0.9% normal saline

Hepatitis C, Chronic Clinical Trial using Simprenavir; Daclatasvir; Ribavarin

Janssen R&D Ireland - Recruiting 18 years or older.
- Phase 2, Open-Label Study to Investigate the Pharmacokinetics, Efficacy, Safety, and Tolerability of the Combination of Simeprevir (TMC435), Daclatasvir (BMS-790052) and Ribavirin (RBV) in Subjects With Recurrent Chronic Hepatitis C Genotype 1b Infection After Orthotopic Liver Transplantation.
Simprenavir; Daclatasvir; Ribavarin

Urinary Tract Infection, Nosocomial Infection, or Bacteriuria Clinical Trial using Povidone-iodine; Chlorhexidine; Normal saline

Mashhad University of Medical Sciences - Recruiting 18 years to 55 years.
- Comparison of the Effect of Applying Povidone-iodine and Chlorhexidine Solutions for Perinea Washing on Bacteriuria Rate and Type in Patients With Urinary Catheter in Intensive Care Unit.
Povidone-iodine; Chlorhexidine; Normal saline

Cystic Fibrosis Clinical Trial using Vancomycin inhalation powder; Placebo inhalation powder

Savara Inc. - Recruiting 12 years or older.
- A Phase 2, Randomized, Double Blind, Placebo-controlled Study of AeroVanc for the Treatment of Persistent Methicillin-resistant Staphylococcus Aureus Lung Infection in Cystic Fibrosis Patients.
Vancomycin inhalation powder; Placebo inhalation powder

Influenza Clinical Trial using CR8020; CR6261; Placebo

Crucell Holland BV - Recruiting 18 years or older.
- Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of CR8020 and CR6261 in Hospitalized Patients With Influenza A Infection.
CR8020; CR6261; Placebo

Uncomplicated Urinary Tract Infection Clinical Trial using Change antibiotics prescribing behaviour of GP

National University of Ireland, Galway, Ireland - Recruiting 18 years or older.
- Supporting the Improvement and Management of Prescribing for Urinary Tract Infections (SIMPle): Protocol for a Randomised Complex Intervention.
Change antibiotics prescribing behaviour of GP

Parainfluenza Clinical Trial using DAS181-F02 Dry Powder in Bulk; DAS181-F02 Nebulized Formulation Inhaled Dose

Ansun Biopharma, Inc. - Recruiting 12 years or older.
- An Open Label Study to Examine the Effects of DAS181 Administered by Dry Powder Inhaler (DPI) or Nebulized Formulation in Immunocompromised Subjects With Parainfluenza (PIV) Infection.
DAS181-F02 Dry Powder in Bulk; DAS181-F02 Nebulized Formulation Inhaled Dose

Human Immunodeficiency Virus Infection Clinical Trial

AbbVie - Recruiting 18 years or older.
- Real Life Effectiveness of KASA: A Prospective Observational Cohort Study.

HIV Infection Clinical Trial

Gilead Sciences - Recruiting N/A or older.
- A Prospective, Observational Study of Pregnancy Outcomes Among Women Exposed to Truvada for PrEP Indication Nested in the Antiretroviral Pregnancy Registry.

Intraabdominal Infections Clinical Trial using Moxifloxacin (Avelox, BAY12-8039); Ertapenem, Amoxicillin/clavulanate

Bayer - Recruiting 3 Months to 17 years.
- A Randomized, Double-blind, Multicenter Trial to Evaluate the Safety and Efficacy of Sequential (Intravenous, Oral) Moxifloxacin Versus Comparator in Pediatric Subjects With Complicated Intra-abdominal Infection.
Moxifloxacin (Avelox, BAY12-8039); Ertapenem, Amoxicillin/clavulanate

Plasmodium Falciparum Infection Clinical Trial using Artemether-lumefantrine 3 days; Artemether-lumefantrine 5 days

University of Oxford - Recruiting 6 years or older.
- An Open-label Randomized Controlled Trial to Evaluate the Effectiveness and Safety of a 3 Day Versus 5 Day Course of Artemether-lumefantrine for the Treatment of Uncomplicated Falciparum Malaria in Myanmar.
Artemether-lumefantrine 3 days; Artemether-lumefantrine 5 days

Cancer, Infection, Inflammation, Tumor, Sarcoid, or Lymphadenopat Clinical Trial

University of Minnesota - Clinical and Translational Science Institute - Recruiting 18 years or older.
- Comparison of 'Wet Suction' Technique to Contemporary 'Dry Suction' Technique Using a 22 Gauge Needle for EUS FNA of Solid Lesions. A Randomized, Prospective, Blinded, and Controlled Trial.

Anal Cancer, HIV Infection, or Human Papilloma Virus Infection Clinical Trial using comparison of screening methods; laboratory biomarker analysis; questionnaire administration; quality-of-life assessment

AIDS Malignancy Clinical Trials Consortium - Recruiting 18 years or older.
- Screening HIV-Infected Women for Anal Cancer Precursors.
comparison of screening methods; laboratory biomarker analysis; questionnaire administration; quality-of-life assessment

Hepatitis C Virus Clinical Trial using ABT-450/r/ABT-267 plus Ribavirin

AbbVie - Recruiting 18 years to 75 years.
- An Open-label Study to Evaluate the Efficacy and Safety of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) Co-administered With Ribavirin (RBV) for 12 or 16 Weeks in Treatment-Na‹ve and Treatment-Experienced Japanese Adults With Genotype 2 Chronic Hepatitis C Virus (HCV) Infection With and Without Compensated Cirrhosis (GIFT-II).
ABT-450/r/ABT-267 plus Ribavirin

HIV-1 Infection Clinical Trial using Placebos of GTU-multiHIV B and LIPO-5 vaccines; GTU-multHIV B vaccine and LIPO-5 vaccine

French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS) - Recruiting 18 years to 59 years.
- Evaluation of a Therapeutic Immunization Strategy Associating a DNA Vaccine (GTU-MultiHIV B) Followed by a Lipopeptide Vaccine (LIPO-5) in the Control of Viral Replication Following Antiretroviral Treatment Interruption in HIV-1 Infected Patients With a CD4 Cell Count ò 600/mm3.
Placebos of GTU-multiHIV B and LIPO-5 vaccines; GTU-multHIV B vaccine and LIPO-5 vaccine

HIV Infection Clinical Trial using adherence reinforcement; Antiretroviral Therapy Darunavir/r + Raltegravir + 2 NRTIs (as chosen by the investigators)

French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS) - Recruiting 18 years or older.
- Systematic 'Adherence Intervention' Phase Before Switching to 3rd-line ART in Patients With 2nd-line ART Virologic Failure in Sub-Saharan Africa : a Phase 2b Non-randomized Study..
adherence reinforcement; Antiretroviral Therapy Darunavir/r + Raltegravir + 2 NRTIs (as chosen by the investigators)

Hepatitis C Clinical Trial using Sofosbuvir; RBV; PEG

Gilead Sciences - Recruiting 18 years or older.
- A Phase 3B Randomized, Open-Label, Multi-Center Trial Assessing Sofosbuvir + Ribavirin for 16 or 24 Weeks and Sofosbuvir + Pegylated Interferon + Ribavirin for 12 Weeks in Subjects With Genotype 2 or 3 Chronic HCV Infection..
Sofosbuvir; RBV; PEG

Pulmonary Arterial Hypertension, HIV Infection, Congenital Heart Clinical Trial using skin biopsy; Blood Sample

Assistance Publique - H“pitaux de Paris - Recruiting 18 years or older.
- Auto-immunity and Prognosis of Pulmonary Arterial Hypertension.
skin biopsy; Blood Sample

Infection, Human Immunodeficiency Virus Clinical Trial using Dolutegravir/abacavir/lamivudine FDC; Atazanavir; Ritonavir; Tenofovir/emtricitabine FDC

ViiV Healthcare - Recruiting 18 years or older.
- A Phase IIIb, Randomized, Open-label Study of the Safety and Efficacy of Dolutegravir/Abacavir/Lamivudine Once Daily Compared to Atazanavir and Ritonavir Plus Tenofovir/Emtricitabine Once Daily in HIV-1 Infected Antiretroviral Therapy Na‹ve Women.
Dolutegravir/abacavir/lamivudine FDC; Atazanavir; Ritonavir; Tenofovir/emtricitabine FDC

Infection of Total Knee Joint Prosthesis Clinical Trial

Rigshospitalet, Denmark - Recruiting 18 years or older.
- Safety Aspects of High-Dose Methylprednisolone in Fast-track Total Knee Arthroplasty.

Human Papillomavirus, or Cancer Clinical Trial using Participants asked questions about recent experiences of anal intercourse in the last six months.; High Resolution Anoscopy

Kirby Institute - Recruiting 35 years or older.
- The Natural History of Anal Human Papillomavirus Infection and Anal Cellular Abnormalities in Homosexual Men.
Participants asked questions about recent experiences of anal intercourse in the last six months.; High Resolution Anoscopy

Infection Clinical Trial

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Recruiting 18 years to 75 years.
- Impact of Acute Infections in Cirrhotic Patients on Body Composition Determined by Bioelectrical Impedance and Vector Analysis.

Acute Hepatitis C Clinical Trial using Peginterferon alfa-2a; Ribavirin

Kirby Institute - Recruiting 16 years or older.
- Treatment of Recently Acquired Hepatitis C Virus Infection.
Peginterferon alfa-2a; Ribavirin

Tuberculosis Clinical Trial using Vaccae; placebo

Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. - Recruiting 15 years to 65 years.
- Phase III Clinical Study of Efficacy and Safety of Mycobacterium Vaccae to Prevent Tuberculosis in High Risk Groups of Tuberculosis Infection.
Vaccae; placebo

HIV-1 Infection, or Pf Subclinical Parasitemia Clinical Trial using Lopinavir/ritonavir; Emtricitabine/tenofovir disoproxil fumarate; Efavirenz; Nevirapine; emtricitabine/tenofovir disoproxil fumarate; trimethoprim/sulfamethoxazole

AIDS Clinical Trials Group - Recruiting 18 years or older.
- An Open-Label, Proof of Concept, Randomized Trial Comparing a LPV/r-Based to an nNRTI-Based Antiretroviral Therapy Regimen for Clearance of Plasmodium Falciparum Subclinical Parasitemia in HIV-infected Adults With CD4+ Counts >200 and <350 Cells/mm3.
Lopinavir/ritonavir; Emtricitabine/tenofovir disoproxil fumarate; Efavirenz; Nevirapine; emtricitabine/tenofovir disoproxil fumarate; trimethoprim/sulfamethoxazole

HIV Infection Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Virologic and Immunologic Evaluation of Lymph Node, Tonsillar, and Intestinal Biopsies, and Bronchoalveolar Lavage Fluid.

Marginal Zone Lymphoma of Ocular Adnexal Clinical Trial using Doxycycline

International Extranodal Lymphoma Study Group (IELSG) - Recruiting 18 years or older.
- International Prospective Phase 2 Trial Addressing the Efficacy of First-line Chlamydophila Psittaci-eradicating Therapy With Protracted Administration of Doxycycline Followed by Eradication Monitoring and Antibiotic Re-treatment at Infection Re-occurrence in Patients With Newly Diagnosed Ocular Adnexal Marginal Zone Lymphoma (OAMZL).
Doxycycline

HIV Infections Clinical Trial using Emtricitabine (FTC); Tenofovir disoproxil fumarate (TDF); Efavirenz (EFV); Truvada

National Institute of Allergy and Infectious Diseases (NIAID) - Recruiting 18 years to 55 years.
- Cellular Pharmacology of Tenofovir and Emtricitabine for HIV Prophylaxis (Cell Prep).
Emtricitabine (FTC); Tenofovir disoproxil fumarate (TDF); Efavirenz (EFV); Truvada

HIV-1 Infection Clinical Trial using Raltegravir; Efavirenz

Taipei Veterans General Hospital, Taiwan - Recruiting 20 years to 60 years.
- An Open Label, Randomized, Parallel Design Estimation Pilot Study to Compare the Efficacy and Safety of Raltegravir-based Versus Efavirenz-based Combination Therapy in Treatment-na‹ve Patients With HIV-1 Infection.
Raltegravir; Efavirenz

Invasive Fungal Infection, or Hematological Malignancy Clinical Trial using voriconazole; voriconazole (dosing according to the SPC)

University Medical Centre Groningen - Recruiting 18 years or older.
- Pharmacologic Optimization of Voriconazole - a Prospective Clustered Group-randomized Cross-over Trial of Therapeutic Drug Monitoring.
voriconazole; voriconazole (dosing according to the SPC)

Candidiasis, Vulvovaginal Clinical Trial using VT-1161 (oral); Fluconazole (oral)

Viamet Pharmaceuticals, Inc. - Recruiting 18 years to 65 years.
- A Phase 2a, Randomized, Double-Blind, Dose Ranging Study to Evaluate the Efficacy and Safety of VT-1161 Oral Tablets Compared to Fluconazole in the Treatment of Patients With Moderate to Severe Acute Vulvovaginal Candidiasis.
VT-1161 (oral); Fluconazole (oral)

Chronic Hepatitis C Infection Clinical Trial using Pegylated Interferon Lambda-1a; Daclatasvir (DCV); Ribasphere (RBV)

Bristol-Myers Squibb - Recruiting 18 years or older.
- Phase 3 Open Label Study Evaluating the Efficacy and Safety of Pegylated Interferon Lambda-1a, in Combination With Ribavirin and Daclatasvir, for Treatment of Chronic HCV Infection With Treatment na‹ve Genotypes 1, 2, 3 or 4 in Subjects Co-infected With HIV.
Pegylated Interferon Lambda-1a; Daclatasvir (DCV); Ribasphere (RBV)

Lung Transplant Infection, or Lower Respiratory Tract Infection Clinical Trial using Dornase Alpha; Isotonic Saline.

The Alfred - Recruiting 18 years or older.
- Investigating the Role of Nebulised Mucolytic Therapy During Lower Respiratory Tract Infections Post Lung Transplantation..
Dornase Alpha; Isotonic Saline.

Infection, Human Immunodeficiency Virus Clinical Trial using DTG; CBZ

ViiV Healthcare - Recruiting 18 years to 65 years.
- A Phase I, Open Label, Randomized, Three Period, Fixed Sequence Crossover Study to Evaluate the Effect of Carbamazepine on Dolutegravir Pharmacokinetics in Healthy Adult Subjects (200901).
DTG; CBZ

Latent Tuberculosis Infection, or Infection in Solid Organ Transp Clinical Trial using Levofloxacin; Isoniazid

Fundaci¢n P£blica Andaluza para la gesti¢n de la Investigaci¢n en Sevilla - Recruiting 18 years or older.
- 'A Prospective, Randomized, Comparative Clinical Trial of the Efficacy and Safety of Levofloxacin Versus Isoniazid in the Treatment of Latent Tuberculosis Infection in Liver Transplant Patients'..
Levofloxacin; Isoniazid

HIV, or Human Immunodeficiency Virus Clinical Trial using Disulfiram

University of California, San Francisco - Recruiting 18 years or older.
- Short-term Disulfiram Administration to Reverse Latent HIV Infection: a Dose Escalation Study.
Disulfiram

Leukemia Clinical Trial using White Blood Cell Transfusion

M.D. Anderson Cancer Center - Recruiting N/A or older.
- A Feasibility Study of White Blood Cell Transfusion for the Prevention of Infection in Acute Myelogenous Leukemia Patients Undergoing Front-Line or First Salvage Induction Therapy.
White Blood Cell Transfusion

Acute Fracture Surgery, Alcohol Cessation Intervention, Postopera Clinical Trial using Gold Standard Programme for Alcohol Cessation Intervention

Bispebjerg Hospital - Recruiting 18 years or older.
- Scand-Ankle: A Gold Standard Programme for Alcohol Cessation Intervention in Patients Undergoing Acute Fracture Surgery - A Randomised Clinical Multi-centre Study.
Gold Standard Programme for Alcohol Cessation Intervention

Colonic Resection Procedures Clinical Trial using Laparoscopic-Assisted Natural Orifice Surgery

University of South Florida - Recruiting 18 years or older.
- Prospective Evaluation of a Laparoscopic-Assisted Transvaginal Approach for Colonic Resection.
Laparoscopic-Assisted Natural Orifice Surgery

Chronic HIV Infection, or HCV Coinfection Clinical Trial using Fosamprenavir

Fundacion SEIMC-GESIDA - Recruiting 18 years or older.
- Randomized, Controlled, Open Label, Pilot Study to Evaluate Fosamprenavir Activity on Genotype 1 Hepatitis C Virus (HCV) Infection Evolution in Human Immunodeficiency Virus (HIV) Co-infected Subjects With Antiretroviral Treatment Including Fosamprenavir.
Fosamprenavir

Bacteremia Clinical Trial using Vancomycin

Duke University - Recruiting 18 years or older.
- A Multi-Center, Randomized, Open-Label, Comparative Study to Assess the Safety and Efficacy of a Treatment Algorithm to Reduce the Use of Vancomycin in Adult Patients With Blood Stream Infections Due to Staphylococci.
Vancomycin

Healthy, or Human Papilloma Virus Infection Clinical Trial using educational intervention; questionnaire administration

Ohio State University Comprehensive Cancer Center - Recruiting 18 years or older.
- The Ohio State University Center for Population Health and Health Disparities Community Awareness, Resources and Education (CARE II): Project 4 The PARENT (Parents in Appalachia Receive Education Needed for Teens) Project.
educational intervention; questionnaire administration

Infection, or Leukemia Clinical Trial using alemtuzumab; polymerase chain reaction; flow cytometry; laboratory biomarker analysis; pharmacological study

National Cancer Institute (NCI) - Recruiting 18 years or older.
- Consolidation Therapy With Alemtuzumab (MabCampathr) in Patients With Chronic Lymphocytic Leukemia Who Are in Complete or Partial 2nd Remission After Cytoreduction With Fludarabine or Fludarabine Plus Cyclophosphamide or Fludarabine Plus Cyclophosphamide Plus Rituximab or Bendamustine or Bendamustine Plus Rituximab - a Phase I/II Study.
alemtuzumab; polymerase chain reaction; flow cytometry; laboratory biomarker analysis; pharmacological study

Surgical Site Infection, Cosmetic Appearance of Cesarean Scar, or Clinical Trial using Silver Plated dressing; Telfa pad dressing

Argentum Medical LLC - Recruiting 18 years or older.
- A Prospective Randomized Study Assessing Post Operative Wound Infections Along With Cosmetic Outcomes Using Silver Plated Dressings Compared to Conventional Dressings on Cesarean Section Incisions.
Silver Plated dressing; Telfa pad dressing

Hepatitis C, or Infection Transmission, Maternal-Fetal Clinical Trial

University of North Carolina, Chapel Hill - Recruiting N/A or older.
- The Pathogenesis of Hepatitis C Virus Vertical Transmission.

Clostridium Difficile Infection Clinical Trial using Fecal Microbiota Transplant

Massachusetts General Hospital - Recruiting 7 years to 90 years.
- Fecal Microbiota Transplant (FMT) for Relapsing Clostridium Difficile Infection in Adults and Children Using a Frozen Encapsulated Inoculum.
Fecal Microbiota Transplant

Invasive Fungal Infection Clinical Trial using voriconazole

Asan Medical Center - Recruiting 15 years or older.
- The Correlation of Voriconazole Trough Plasma Levels With Genetic Polymorphism, Efficacy, and Safety Outcomes in Hematologic Malignancy Patients With Invasive Pulmonary Aspergillosis.
voriconazole

HIV-2 Infection Clinical Trial using emtricitabine / tenofovir disoproxil fumarate / raltegravir .

French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS) - Recruiting 18 years or older.
- ANRS 159 VIH-2 : Trial Evaluating a First Line Combination Therapy With Raltegravir, Emtricitabine and Tenofovir in HIV-2 Infected Patients.
emtricitabine / tenofovir disoproxil fumarate / raltegravir .

Infection, or Vasculitis Clinical Trial using PET/CT

Turku University Hospital - Recruiting 18 years or older.
- Positron Emission Tomography of Infection and Vasculitis (PETU).
PET/CT

Human Immunodeficiency Virus Clinical Trial using TwHF; placebo treatment

Beijing 302 Hospital - Recruiting 18 years to 60 years.
- Phase 1/2 Study of Tripterygium Wilfordii Hook F (TwHF) Treatment for Evaluation the Efficacy and Safety in Immune Non-responders With HIV-1 Infection.
TwHF; placebo treatment

Chronic Hepatitis C Clinical Trial

Beijing 302 Hospital - Recruiting 1 year to 18 years.
- Pharmacogenomics Study on IL28B Genetic Variants for Prediction of Drug Response in Chinese Children With HCV Infection..

Sepsis, Umbilical Cord, or Infection Clinical Trial using Perinatal Handwashing Promotion; Neonatal Health Promotion

International Centre for Diarrhoeal Disease Research, Bangladesh - Recruiting N/A or older.
- Development and Evaluation of Perinatal Handwashing Promotion for Improved Maternal Handwashing Behavior.
Perinatal Handwashing Promotion; Neonatal Health Promotion

HIV Infection Clinical Trial

Bristol-Myers Squibb - Recruiting N/A to 17 years.
- Post-marketing Safety Surveillance Program in HIV-infected Children Exposed to Atazanavir in Europe.

HIV Clinical Trial using (FDC) ELV/COBI/FTC/TDF

Duke University - Recruiting 18 years to 75 years.
- Treatment of Acute HIV Infection With the Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Disoproxil Fumarate, A Pilot Study of Response to Therapy and HIV Pathogenesis.
(FDC) ELV/COBI/FTC/TDF

Urinary Tract Infection Clinical Trial

Mayo Clinic - Recruiting 65 years or older.
- Diagnosis of Subclinical Urinary Tract Infections Using Advanced Microbiome Survey Techniques in High Risk Trauma Patients.

Crohn's Disease, Ulcerative Colitis, Clostridium Difficile, or In Clinical Trial using Blood and stool sample

Boston Medical Center - Recruiting 18 years or older.
- Host Immune Response to Clostridium Difficile Infection in Inflammatory Bowel Disease Patients.
Blood and stool sample

Bacterial Infection Clinical Trial using No intervention

Duke University - Recruiting 18 years or older.
- Study of the Temporal Profile and Bi-directional Transmission of Microorganisms Between Patients and Environmental Surfaces..
No intervention

Surgical Site Infection, Closed Suction Drains Clinical Trial

Western Galilee Hospital-Nahariya - Recruiting N/A or older.
- Bacterial Colonization of Suction Drains Following Spine Surgery.

HIV Infection Clinical Trial using antiretroviral treatment

Hospital Clinic of Barcelona - Recruiting 18 years or older.
- Study to Evaluate the Activity and Tolerability of Lopinavir/Ritonavir and Lamivudine Bitherapy Instead of a Triple Therapy That Includes Lopinavir/Ritonavir and Lamivudine or Emtricitabine in HIV Patients With Viral Suppression: Controlled Clinical Trial, Open Label, Randomized, of 48 Weeks of Follow-up.
antiretroviral treatment

Hazardous Alcohol Use, Binge Drinking, High Risk Sexual Behaviors Clinical Trial using Computerized brief alcohol intervention with IVR booster calls; Computer delivered brief alcohol intervention; Attention Control

Johns Hopkins University - Recruiting 18 years or older.
- Computerized BI for Binge Drinking HIV At-Risk and Infected African-American Women.
Computerized brief alcohol intervention with IVR booster calls; Computer delivered brief alcohol intervention; Attention Control

Influenza Infection Clinical Trial using green tea

University of Shizuoka - Recruiting 15 years to 20 years.
- Effects of Gargling With Green Tea on Preventing Influenza Infection Among High School Students: A Randomized Clinical Study.
green tea

Acute Uncomplicated Malaria With PVivax Infection Clinical Trial using Artesunate; Chloroquine

Mahidol University - Recruiting 18 years to 65 years.
- An Open Label Randomized Comparison of Two Antimalarial Drugs Regimens in Patient With Plasmodium Vivax Malaria in Thailand.
Artesunate; Chloroquine

Influenza Virus Infection Transmission in Humans Clinical Trial

University of Maryland - Recruiting 10 years or older.
- Evaluating Modes of Influenza Transmission Work Package 1: Observational Study of Community Acquired Influenza.

Helicobacter Pylori Infection Clinical Trial using PPI, amoxicillin, metronidazole and clarithromycin

Infante, Javier Molina, M.D. - Recruiting 18 years or older.
- Phase 4, Prospective, Randomized Study Comparing 14-day Non-bismuth Quadruple 'Hybrid' and 'Concomitant' Therapies for Helicobacter Pylori Eradication in Settings With High Clarithromycin Resistance.
PPI, amoxicillin, metronidazole and clarithromycin

Cesarean Delivery, Postpartum Infection, Wound Complications, Wou Clinical Trial using Prevena negative pressure wound system

University of Iowa - Recruiting 18 years to 55 years.
- Negative Pressure Wound Therapy to Prevent Post Operative Wound Complications Following Cesarean Delivery in Women at High Risk for Wound Complications.
Prevena negative pressure wound system

Malaria, or Plasmodium Falciparum Clinical Trial using PfSPZ Challenge; Normal Saline (NS)

Sanaria Inc. - Recruiting 18 years to 35 years.
- Controlled Human Malaria Infection (CHMI) After Immunization With Cryopreserved Plasmodium Falciparum Sporozoites Under Chloroquine Prophylaxis.
PfSPZ Challenge; Normal Saline (NS)

Nosocomial Infection Clinical Trial using Glutamine; Maltodextrin

University of Alberta - Recruiting 18 years or older.
- GLutamine Enterally After carDiac Surgery for Inflammation Attenuation and ouTcOme impRovement (GLADIATOR): A Phase II Randomized, Blinded, Placebo-Controlled Trial.
Glutamine; Maltodextrin

Hepatitis C Clinical Trial using rimantadine

The Leeds Teaching Hospitals NHS Trust - Recruiting 18 years to 65 years.
- A Clinical Study to Evaluate the Biological Effects of Administering Rimantadine in Patients With Hepatitis C Virus (HCV) Infection Alongside Standard Combination Therapy With Pegylated Interferon and Ribavirin.
rimantadine

Tuberculosis Infection Clinical Trial using To confirm the potency of Aplisol formulated with newly produced Tuberculin PPD compared to PPD-S2 standard.; Reactivity of Aplisol compared to reference standard PPD-S2.

JHP Pharmaceuticals LLC - Recruiting 18 years to 60 years.
- Dose Comparison Study of Tuberculin Purified Protein Derivative (PPD)With Standard Tuberculin Purified Protein Derivative..
To confirm the potency of Aplisol formulated with newly produced Tuberculin PPD compared to PPD-S2 standard.; Reactivity of Aplisol compared to reference standard PPD-S2.

Urinary Tract Infection Clinical Trial using ICETT TIC Foley Catheter; BARDr LUBRI-SILr IC Foley Catheter

Innovative Chemical and Environmental Technologies, Inc - Recruiting 18 years or older.
- A Randomized Trial for the Safety and Effectiveness of a Novel Antimicrobial-Coated Foley Catheter Attached to an Antimicrobial Anti-Reflux Device for Reduction of Catheter-Associated Urinary Tract Infection.
ICETT TIC Foley Catheter; BARDr LUBRI-SILr IC Foley Catheter

High Triglyceride Level, or HIV Infection Clinical Trial using Lovaza

Tufts University - Recruiting 18 years or older.
- The Impact of Omega Three Fatty Acids on Vascular Function in HIV.
Lovaza

Coronary Artery Bypass Graft, or Median Sternotomy Clinical Trial

Samsung Medical Center - Recruiting 20 years to 90 years.
- Risk Factors of Sternal Wound Infection After Coronary Artery Bypass Graft.

Tuberculosis Clinical Trial

Singapore General Hospital - Recruiting 21 years or older.
- Prospective Database of All Patients With Microbiologically Proven Mycobacteria Tuberculosis Infection Treated at Singapore General Hospital.

Infection in Solid Organ Transplant Recipients Clinical Trial using Pneumococcal Conjugate Vaccine 13 (PCV13)

University of California, Los Angeles - Recruiting 12 Months to 59 Months.
- Safety And Long-Term Immunogenicity Of The 13-Valent Pneumococcal Conjugate Vaccine In Children Who Are Solid Organ Transplant Recipients.
Pneumococcal Conjugate Vaccine 13 (PCV13)

Schistosoma Hematobium Infection, or Schistosomiasis Mansoni Clinical Trial using Myrrh

Pharco Pharmaceuticals - Recruiting 15 years to 30 years.
- Safety and Efficacy of Mirazid for Schistosomiasis Treatment as Compared to Praziquantel: An Open-label Randomized Non-placebo-Controlled Study.
Myrrh

Antibiotic Resistant Infection Clinical Trial using Tigecycline

Mahidol University - Recruiting 18 years or older.
- Effectiveness and Safety of Tigecycline for Therapy of Infections Caused by Multi-Drug Resistant Acinetobacter Baumannii.
Tigecycline

Respiratory Tract Infections, Bronchiolitis Obliterans, Cryptogen Clinical Trial using Prednisone; Azithromycin; Montelukast; Symbicort

Maisonneuve-Rosemont Hospital - Recruiting 18 years or older.
- Does Increasing Immunosuppression Prevent Transplant-associated Lung-disease Triggered by Viral Respiratory Tract Infection Following Allogeneic Stem Cell Transplant? A Pilot Study.
Prednisone; Azithromycin; Montelukast; Symbicort

Type 2 Diabetes, or Peripheral Vascular Disease Clinical Trial using Subjects with diabetes who plan to undergo elective infrainguinal bypass surgery will receive standard diabetes care by their admitting physician; Subjects with diabetes who plan to undergo elective infrainguinal bypass surgery will receive diabetes care under the direction of the Diabetes Action Team; Subjects without diabetes will have their blood glucose levels monitored while in the hospital

University of British Columbia - Recruiting 30 years or older.
- Early Post-Operative Dysglycemia in Patients With and Without Diabetes Post-Infrainguinal Bypass Surgery and the Effectiveness of a Diabetes Action Team in the Management of Diabetes Post Infrainguinal Bypass Surgery on Glycemic Control, Length of Stay, and Infection Rates: A Pilot Study.
Subjects with diabetes who plan to undergo elective infrainguinal bypass surgery will receive standard diabetes care by their admitting physician; Subjects with diabetes who plan to undergo elective infrainguinal bypass surgery will receive diabetes care under the direction of the Diabetes Action Team; Subjects without diabetes will have their blood glucose levels monitored while in the hospital

HIV Infection, or Pulmonary TB Clinical Trial using ATT (Ethambutol, Pyrazinamide, INH, Rifampicin)

Tuberculosis Research Centre, India - Recruiting 18 years or older.
- A Randomized Controlled Clinical Trial Comparing Daily Vs. Intermittent 6 - Month Short Course Chemotherapy in Reducing Failures & Emergence of Acquired Rifampicin Resistance (ARR) in Patients With HIV and Pulmonary Tuberculosis.
ATT (Ethambutol, Pyrazinamide, INH, Rifampicin)

Bile Duct Stricture, or Choledocholithiasis Clinical Trial using Blood draw for culture

Stanford University - Recruiting 18 years to 80 years.
- Prospective Study of Bacteremia and Infection Rates Following Cholangioscopy With the Spyglass Cholangioscope.
Blood draw for culture

Latent Tuberculosis Infection Clinical Trial

Germans Trias i Pujol Hospital - Recruiting 18 years or older.
- Demonstration of the Dynamic Hypothesis of Latent Tuberculosis Infection.

Infection Clinical Trial using Vancomycin; Vancomycin and Gentamycin; Cefuroxime

Ganga Hospital - Recruiting 10 years or older.
- Effects of Applying Powdered Prophylactics Verses Intravenous Antibiotics Only on Post-operative Infection Rate.
Vancomycin; Vancomycin and Gentamycin; Cefuroxime

HIV Infection Clinical Trial

Istituto Superiore di Sanita - Recruiting 18 years to 45 years.
- A Multicentre, Observational, Cross-sectional Study to Assess the Seroprevalence of Anti-Tat Antibodies in HIV-infected Patients in Selected Areas of Gauteng and Eastern Cape.

Hepatitis C, Chronic, or HIV Infection Clinical Trial using Adherence questionnaire

Fundacion IMIM - Recruiting 18 years or older.
- Development and Validation of a Questionnaire Measuring Treatment Adherence in Patients With Hepatitis C.
Adherence questionnaire

Vaginosis, Bacterial, Infertility, or Miscarriage Clinical Trial using Metronidazole; Placebo

Stanford University - Recruiting 18 years or older.
- Pregnancy Outcomes Following Preconception Treatment of Asymptomatic Bacterial Vaginosis in an Infertility Population: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial..
Metronidazole; Placebo

Head and Neck Cancer, Infection, or Malnutrition Clinical Trial using therapeutic nutritional supplementation; placebo

National Cancer Institute (NCI) - Recruiting 18 years to 75 years.
- Role of Peri-operative Immunonutrition in Cancers of the Higher Aero-digestive Tract.
therapeutic nutritional supplementation; placebo

Tuberculosis, or HIV Infections Clinical Trial using Emtricitabine/tenofovir/efavirenz

African Poverty Related Infection Oriented Research Initiative - Recruiting 18 years to 65 years.
- The Pharmacokinetics of Co-formulated Emtricitabine/Tenofovir/Efavirenz in HIV-infected Patients With Smear-positive Pulmonary Tuberculosis in the Kilimanjaro Region, Tanzania.
Emtricitabine/tenofovir/efavirenz

The Patients Who Receive Percutaneous Endoscopic Gastrostomy, Per Clinical Trial using cefuroxime; Tailored antibiotic

National Cheng Kung University - Recruiting 20 years to 80 years.
- Impact of Oropharyngeal Microorganism Colonization on the Peristomal Infection After Percutaneous Endoscopic Gastrostomy and the Effect of Tailored Antibiotics Prophylaxis.
cefuroxime; Tailored antibiotic

Intra-amniotic Infection Clinical Trial

ProteoGenix, Inc. - Recruiting 18 years or older.
- Development of a Non-invasive Test to Detect Intra-amniotic Infection and Predict Preterm Birth in Women Presenting With Preterm Labor and and Intact Amniotic Membranes.

Bacterial Infection, or Brain Injury Clinical Trial using cefotaxime; Metronidazole; Ciprofloxacin; Fosfocine

Poitiers University Hospital - Recruiting 18 years or older.
- .
cefotaxime; Metronidazole; Ciprofloxacin; Fosfocine

Gastrointestinal Neoplasms Clinical Trial

Komagome Hospital - Recruiting 20 years to 70 years.
- Bone Marrow-derived Cells' Contribution to Tumor Formation and Epithelial Cells Regeneration in the Gastrointestinal Tract.

Chronic HCV Infection, or Nonalcoholic Steatohepatitis Clinical Trial using pegylated interferon; Ribavarin

Charles University, Czech Republic - Recruiting 18 years to 60 years.
- Role of Heme Oxygenase in the Pathogenesis od Hepatocellular Injury in Chronic HCV Infection.
pegylated interferon; Ribavarin

Infection Clinical Trial using Biopsy

The Woman's Hospital of Texas - Recruiting 18 years to 48 years.
- Myometrial Biopsy for the Detection of Infection.
Biopsy

Infant, Newborn, Diseases, Sepsis, or Puerperal Infection Clinical Trial using Chlorhexidine; Birth canal wipe; sterile water external genital wipe

Centers for Disease Control and Prevention - Recruiting 15 years or older.
- Preventing Serious Neonatal and Maternal Peripartum Infections in Developing Country Settings With a High Prevalence of HIV Infection: Assessment of the Disease Burden and Evaluation of an Affordable Intervention in Soweto, South Africa.
Chlorhexidine; Birth canal wipe; sterile water external genital wipe

HIV Infections Clinical Trial

National Institute of Allergy and Infectious Diseases (NIAID) - Recruiting 18 years to 60 years.
- Evaluation of HIV-Specific Immunological and Virological Responses of HIV-1 Multiply-Exposed Seronegative Individuals.

Invasive Fungal Infection, Aspergillosis, Fungemia, or Hematopoie Clinical Trial

Peking University - Recruiting N/A or older.
- The Value of Real-Time Polymerase Chain Reaction (RT-PCR) Assay, Galactomannan and á-D-Glucan Detection (GM/G-Test) for Diagnosis of Invasive Fungal Infection (IFI) in Chinese Patients After Hematopoietic Stem Cell Transplantation (HSCT).

Liver Transplantation, or Fungal Infection Clinical Trial using Caspofungin

Grupo de Estudio de Infecciones en Transplantados - Recruiting 18 years or older.
- Prophylaxis With Caspofungin for the Prevention of Invasive Fungal Infections in High-Risk Liver Transplant Recipients.
Caspofungin

Tuberculosis, Latent Tuberculosis, Tuberculosis Contact, or Elder Clinical Trial using tuberculin for skin test

Taichung Veterans General Hospital - Recruiting N/A or older.
- Phase IV Study of the Quantiferon-RD1 Test.
tuberculin for skin test

HIV Infection, or AIDS Clinical Trial using once daily minimum 3-drug regimen of anti-retroviral medications

407 Doctors - Recruiting 18 years or older.
- A Randomised, Multi-Centre, Open-Label Study in Well-Controlled Treatment-Experienced HIV-Infected Patients to Assess Compliance With a Once-Daily Regimen of Lamivudine, Efavirenz and Didanosine Versus Continuation of Current Anti-Retroviral Regimen Delivered at Least Twice Daily.
once daily minimum 3-drug regimen of anti-retroviral medications